data_2k14_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k14 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 113.835 1.05 . . . . 1.0 113.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.202 0.816 . . . . 1.0 113.202 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.964 1.098 . . . . 1.0 113.964 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.806 0.669 . . . . 1.0 112.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 108.066 -1.087 . . . . 1.0 108.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.029 1.122 . . . . 1.0 114.029 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.048 0.758 . . . . 1.0 113.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.282 0.845 . . . . 1.0 113.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.71 1.374 . . . . 1.0 114.71 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.498 1.296 . . . . 1.0 114.498 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.924 0.713 . . . . 1.0 112.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 113.126 0.787 . . . . 1.0 113.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.914 0.709 . . . . 1.0 112.914 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.456 1.28 . . . . 1.0 114.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.412 0 N-CA-C 114.718 0.647 . . . . 1.0 114.718 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p -55.77 -35.29 66.07 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.894 1.278 . . . . 1.0 113.835 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.49 -26.12 68.57 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.19 -30.39 70.39 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.969 -1.082 . . . . 1.0 112.796 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.33 -14.92 61.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.32 1.048 . . . . 1.0 113.202 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -59.91 -15.24 20.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 45.83 1.64 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.573 1.558 . . . . 1.0 112.988 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 pp -49.92 -26.03 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 116.383 1.994 . . . . 1.0 116.383 -169.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.97 -5.65 88.88 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.773 1.178 . . . . 1.0 115.264 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.73 28.23 0.84 Allowed Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.749 1.274 . . . . 1.0 114.78 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -136.21 174.39 10.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.221 1.808 . . . . 1.0 111.538 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -130.24 138.4 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.572 1.549 . . . . 1.0 109.46 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -36.07 78.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 35.17 58.6 2.52 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.012 2.125 . . . . 1.0 114.64 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.88 161.88 43.78 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.32 2.68 . . . . 1.0 112.811 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.963 1.305 . . . . 1.0 113.338 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 N-CA-C 114.764 0.666 . . . . 1.0 114.764 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p -55.87 -39.52 71.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.922 1.289 . . . . 1.0 113.815 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -61.62 -22.92 65.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.2 -30.49 71.55 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.845 1.202 . . . . 1.0 112.606 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt -67.39 -13.51 62.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.47 1.108 . . . . 1.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.46 -15.53 7.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.22 40.11 1.23 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.213 1.387 . . . . 1.0 114.065 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.82 -26.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.367 2.267 . . . . 1.0 116.556 -169.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.23 -16.45 57.96 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 124.49 1.043 . . . . 1.0 115.356 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.81 -10.49 0.11 Allowed Glycine 0 CA--C 1.541 1.715 0 N-CA-C 116.875 1.51 . . . . 1.0 116.875 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.9 p -72.72 -179.97 3.34 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.568 1.684 . . . . 1.0 112.874 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -128.63 136.58 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.927 1.691 . . . . 1.0 109.608 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -38.63 91.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 35.71 56.88 2.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 126.553 1.941 . . . . 1.0 115.249 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.24 158.38 57.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.217 2.612 . . . . 1.0 112.649 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.149 1.78 . . . . 1.0 109.978 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.378 0 N-CA-C 114.704 0.642 . . . . 1.0 114.704 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -56.35 -29.54 61.51 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.945 1.298 . . . . 1.0 113.964 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -63.1 -26.54 68.88 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.09 -30.31 70.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.871 -1.143 . . . . 1.0 112.922 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.96 -14.96 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.893 0.877 . . . . 1.0 113.019 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.01 -13.39 4.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.67 39.52 1.3 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.136 1.351 . . . . 1.0 113.818 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -26.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 127.538 2.335 . . . . 1.0 116.51 -169.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.59 -16.34 55.26 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.424 1.012 . . . . 1.0 115.406 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.24 -11.34 0.09 OUTLIER Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.906 1.522 . . . . 1.0 116.906 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.37 175.09 5.71 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.757 1.779 . . . . 1.0 112.891 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.96 135.82 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.553 1.541 . . . . 1.0 109.737 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -38.59 91.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 37.16 56.53 3.74 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 125.884 1.673 . . . . 1.0 115.02 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.62 160.87 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.177 2.585 . . . . 1.0 112.828 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.808 1.243 . . . . 1.0 110.845 177.145 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.321 0 N-CA-C 114.801 0.68 . . . . 1.0 114.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p -56.9 -30.18 63.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.8 -26.51 68.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.64 -30.57 69.96 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.989 -1.069 . . . . 1.0 112.805 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.19 -14.96 61.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.932 0.893 . . . . 1.0 112.806 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.33 -17.34 7.49 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.62 40.11 1.12 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.292 1.425 . . . . 1.0 114.347 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.9 -26.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.469 2.307 . . . . 1.0 116.511 -169.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.03 -16.32 57.34 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.448 1.023 . . . . 1.0 115.325 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.14 -11.18 0.1 OUTLIER Glycine 0 CA--C 1.541 1.66 0 N-CA-C 116.861 1.505 . . . . 1.0 116.861 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -71.55 175.43 5.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.709 1.755 . . . . 1.0 112.801 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.03 136.58 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.506 1.522 . . . . 1.0 109.802 -171.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -37.33 77.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 38.79 55.98 5.26 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.179 1.792 . . . . 1.0 114.946 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -67.69 159.0 54.64 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.33 2.687 . . . . 1.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.059 1.744 . . . . 1.0 109.973 -177.434 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.481 0.553 . . . . 1.0 114.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p -56.72 -39.88 74.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.423 1.112 . . . . 1.0 112.719 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.07 -25.47 68.12 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.51 -30.45 71.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.951 -1.093 . . . . 1.0 112.328 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.81 -12.42 54.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.28 1.032 . . . . 1.0 112.954 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.37 -18.33 6.5 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.8 46.18 2.58 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.281 1.42 . . . . 1.0 112.409 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.11 -26.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.551 2.341 . . . . 1.0 116.366 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.92 -5.48 77.32 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.328 1.442 . . . . 1.0 115.239 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.83 28.6 2.01 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.066 1.793 . . . . 1.0 113.554 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.6 p -136.79 178.91 6.71 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.341 2.256 . . . . 1.0 110.72 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.87 124.94 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 1.0 108.514 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -60.64 -37.25 80.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 35.8 55.53 2.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 127.512 2.325 . . . . 1.0 115.291 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -68.55 157.26 62.55 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.148 2.566 . . . . 1.0 112.361 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 126.006 1.722 . . . . 1.0 110.067 -176.335 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.292 0 N-CA-C 114.748 0.659 . . . . 1.0 114.748 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p -56.09 -35.95 67.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.673 1.189 . . . . 1.0 113.304 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.05 -30.52 70.37 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.006 -1.059 . . . . 1.0 112.938 170.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.7 -14.75 61.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.769 0.828 . . . . 1.0 113.017 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -53.76 -21.57 7.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 46.08 1.65 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.118 1.342 . . . . 1.0 113.671 169.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -48.65 -26.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 127.187 2.195 . . . . 1.0 115.484 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.31 -5.38 76.05 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.376 1.465 . . . . 1.0 115.203 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.6 27.62 2.07 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.275 1.893 . . . . 1.0 113.575 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 p -136.18 178.86 6.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.369 2.267 . . . . 1.0 110.697 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt -128.91 124.81 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.25 1.42 . . . . 1.0 108.066 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -63.7 -35.84 81.88 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 35.21 52.03 1.42 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 127.153 2.181 . . . . 1.0 116.602 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -68.51 158.57 57.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.092 2.528 . . . . 1.0 112.738 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 126.059 1.744 . . . . 1.0 109.972 -177.521 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 N-CA-C 114.739 0.656 . . . . 1.0 114.739 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p -55.81 -33.92 64.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.817 1.247 . . . . 1.0 114.029 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.69 -29.69 70.69 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.63 -30.46 69.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.129 -0.982 . . . . 1.0 112.831 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.65 -20.54 64.91 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -49.76 -19.3 0.62 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.47 40.25 1.76 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.757 1.17 . . . . 1.0 113.206 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.11 -26.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 129.183 2.993 . . . . 1.0 116.426 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.82 -11.67 85.22 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.828 1.204 . . . . 1.0 115.208 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.48 0.28 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.097 1.332 . . . . 1.0 115.389 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.81 179.37 3.18 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.911 1.356 . . . . 1.0 111.93 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.59 133.36 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.422 1.489 . . . . 1.0 109.346 -172.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.26 -35.14 79.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 39.0 53.93 4.61 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 126.765 2.026 . . . . 1.0 115.025 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -68.16 157.91 59.74 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.15 2.567 . . . . 1.0 112.595 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.749 1.619 . . . . 1.0 109.785 -178.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 114.798 0.679 . . . . 1.0 114.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m -54.68 -35.75 63.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.948 1.299 . . . . 1.0 114.015 -175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.02 -22.18 66.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.02 -30.53 71.51 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.929 -1.107 . . . . 1.0 112.392 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt -66.06 -13.99 60.93 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.714 1.206 . . . . 1.0 113.048 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.64 -12.29 6.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.42 40.66 0.92 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.508 1.528 . . . . 1.0 114.067 169.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.35 -22.2 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 127.585 2.354 . . . . 1.0 116.951 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -16.77 62.95 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.419 1.009 . . . . 1.0 115.085 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.95 -9.98 0.09 OUTLIER Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.086 1.594 . . . . 1.0 117.086 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.14 172.36 9.34 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 119.802 1.801 . . . . 1.0 113.123 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt -129.42 138.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.693 1.597 . . . . 1.0 109.689 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -36.0 81.81 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 38.95 54.27 4.75 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 126.869 2.067 . . . . 1.0 114.776 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.72 159.33 53.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.417 2.745 . . . . 1.0 112.745 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.603 1.561 . . . . 1.0 110.435 -178.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 114.503 0.561 . . . . 1.0 114.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -57.17 -37.27 71.85 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.413 1.107 . . . . 1.0 112.84 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.03 -20.83 59.91 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.11 -38.23 90.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.24 -0.912 . . . . 1.0 112.373 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.08 -24.38 65.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.395 1.078 . . . . 1.0 112.191 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -59.77 -12.83 8.04 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.78 40.96 1.0 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.329 1.442 . . . . 1.0 113.887 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.252 1.8 pp -47.84 -22.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 127.823 2.449 . . . . 1.0 116.987 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.16 -16.48 64.59 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.419 1.009 . . . . 1.0 114.998 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.5 -10.57 0.1 OUTLIER Glycine 0 CA--C 1.541 1.684 0 N-CA-C 116.939 1.536 . . . . 1.0 116.939 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.0 p -71.15 173.24 7.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.77 1.785 . . . . 1.0 113.074 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt -129.53 140.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.793 1.637 . . . . 1.0 109.617 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -37.66 78.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 38.12 56.05 4.6 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.278 1.831 . . . . 1.0 115.083 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -68.15 159.81 51.53 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.232 2.622 . . . . 1.0 112.684 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.2 mm . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.575 1.15 . . . . 1.0 111.366 177.627 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.282 0 N-CA-C 114.641 0.616 . . . . 1.0 114.641 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -56.36 -29.82 61.87 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.936 1.294 . . . . 1.0 113.894 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.18 -23.92 67.65 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.27 -30.59 71.7 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.028 -1.045 . . . . 1.0 112.463 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt -67.63 -13.1 61.79 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.623 1.169 . . . . 1.0 113.282 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -58.3 -9.93 1.78 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.98 42.21 1.33 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.917 1.246 . . . . 1.0 113.067 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.17 -26.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.743 2.417 . . . . 1.0 116.407 -169.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.82 -15.29 62.1 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.506 1.051 . . . . 1.0 115.311 172.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.95 -9.86 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 N-CA-C 116.791 1.477 . . . . 1.0 116.791 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.3 p -69.42 173.13 6.18 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.697 1.749 . . . . 1.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm -128.36 127.78 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.52 1.528 . . . . 1.0 108.648 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.6 -35.25 80.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 38.99 53.63 4.45 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 126.886 2.074 . . . . 1.0 115.17 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.51 157.27 62.55 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.129 2.553 . . . . 1.0 112.356 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 125.986 1.714 . . . . 1.0 109.971 -176.604 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 N-CA-C 114.658 0.623 . . . . 1.0 114.658 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -56.96 -31.75 65.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.719 1.208 . . . . 1.0 113.675 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.44 -25.67 68.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.79 -30.53 70.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.941 -1.1 . . . . 1.0 112.842 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.49 -14.73 62.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.044 0.938 . . . . 1.0 112.992 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -50.62 -17.88 0.6 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.86 40.2 1.84 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.794 1.187 . . . . 1.0 113.006 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.04 -26.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 129.287 3.035 . . . . 1.0 116.45 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.56 85.44 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.87 1.224 . . . . 1.0 115.209 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.4 0.29 Allowed Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.18 1.372 . . . . 1.0 115.461 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -71.14 177.69 3.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.927 1.363 . . . . 1.0 111.931 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -128.76 130.11 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.092 1.357 . . . . 1.0 108.996 -173.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.63 -38.68 90.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 35.36 56.5 2.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.711 2.004 . . . . 1.0 115.394 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.83 158.37 58.13 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.07 2.513 . . . . 1.0 112.677 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.478 0.93 0 C-N-CA 125.779 1.632 . . . . 1.0 109.761 -179.311 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.335 0 N-CA-C 114.869 0.707 . . . . 1.0 114.869 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -54.61 -30.0 53.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.543 1.537 . . . . 1.0 114.71 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.18 -25.48 68.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.75 -30.47 70.8 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.869 -1.144 . . . . 1.0 112.603 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt -64.39 -13.69 52.29 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.022 0.929 . . . . 1.0 112.923 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.51 -14.71 5.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.8 39.56 1.12 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.218 1.39 . . . . 1.0 114.223 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.15 -26.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 127.486 2.314 . . . . 1.0 116.514 -169.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -16.22 55.82 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.413 1.006 . . . . 1.0 115.387 171.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.46 -12.36 0.1 OUTLIER Glycine 0 CA--C 1.54 1.639 0 N-CA-C 116.864 1.506 . . . . 1.0 116.864 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.0 p -71.51 174.32 6.79 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.679 1.74 . . . . 1.0 112.741 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.13 138.52 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.699 1.6 . . . . 1.0 109.519 -172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -88.91 -37.44 15.28 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 28.89 61.68 0.74 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.956 2.502 . . . . 1.0 115.251 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.93 163.17 39.41 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.378 2.719 . . . . 1.0 112.857 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.035 1.334 . . . . 1.0 113.394 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 114.817 0.687 . . . . 1.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p -53.69 -35.09 60.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 1.0 114.498 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.71 -20.85 62.1 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.55 -30.8 71.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.51 1.05 . . . . 1.0 113.017 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.7 -14.27 62.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.366 1.067 . . . . 1.0 112.358 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.23 -19.83 5.92 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 47.49 2.78 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.224 1.392 . . . . 1.0 112.574 169.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.57 -26.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 127.424 2.289 . . . . 1.0 115.829 -169.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.37 -5.48 79.32 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.254 1.406 . . . . 1.0 115.297 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.93 28.15 1.87 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.967 1.746 . . . . 1.0 113.705 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.7 p -136.56 179.2 6.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.248 2.219 . . . . 1.0 110.841 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.82 127.12 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.175 1.39 . . . . 1.0 108.717 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -37.08 74.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 38.29 56.2 4.81 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 126.33 1.852 . . . . 1.0 114.939 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.24 161.37 44.9 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.313 2.675 . . . . 1.0 112.801 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 125.675 1.59 . . . . 1.0 112.759 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.842 0.697 . . . . 1.0 114.842 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p -55.83 -33.72 64.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.817 1.247 . . . . 1.0 114.034 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.83 -23.99 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.97 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.774 1.17 . . . . 1.0 112.477 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.29 -14.37 61.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.322 1.049 . . . . 1.0 112.863 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -57.72 -15.58 8.37 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 40.95 0.8 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.686 1.612 . . . . 1.0 114.505 170.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.23 -22.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 127.568 2.347 . . . . 1.0 116.92 -169.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -16.58 62.54 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.398 0.999 . . . . 1.0 115.041 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.7 -10.52 0.09 OUTLIER Glycine 0 CA--C 1.542 1.729 0 N-CA-C 117.016 1.566 . . . . 1.0 117.016 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.05 171.91 10.06 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.755 1.777 . . . . 1.0 113.086 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.01 138.57 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.661 1.584 . . . . 1.0 109.729 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.55 -34.83 78.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 35.18 61.14 2.46 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.172 2.189 . . . . 1.0 114.787 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.38 146.52 40.82 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.539 2.826 . . . . 1.0 114.067 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.471 0.613 0 C-N-CA 126.162 1.785 . . . . 1.0 112.784 -177.423 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 N-CA-C 114.804 0.681 . . . . 1.0 114.804 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -55.42 -30.45 60.48 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.098 1.359 . . . . 1.0 114.098 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.66 -25.98 68.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.46 -30.31 70.51 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.921 -1.112 . . . . 1.0 112.68 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.91 -14.7 55.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.924 0.889 . . . . 1.0 112.923 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -58.33 -14.08 6.67 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.44 40.57 0.92 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.425 1.488 . . . . 1.0 114.01 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 pp -47.81 -22.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.746 2.419 . . . . 1.0 117.03 -169.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.79 -16.16 65.55 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.494 1.045 . . . . 1.0 115.068 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.76 -9.94 0.1 OUTLIER Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.984 1.554 . . . . 1.0 116.984 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -70.98 175.07 5.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.694 1.747 . . . . 1.0 112.995 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.71 136.43 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 1.0 109.574 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -38.25 87.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 36.28 56.3 3.04 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.551 1.94 . . . . 1.0 115.295 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.59 159.28 54.24 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.266 2.644 . . . . 1.0 112.656 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 125.709 1.604 . . . . 1.0 109.769 -179.375 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 114.486 0.555 . . . . 1.0 114.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p -57.3 -36.49 71.15 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.43 1.115 . . . . 1.0 112.924 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.27 -29.6 68.91 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.26 -30.04 70.22 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.205 -0.934 . . . . 1.0 112.775 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.07 -12.63 61.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.725 1.21 . . . . 1.0 113.556 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.42 -15.68 7.35 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.87 41.01 0.84 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.587 1.565 . . . . 1.0 114.414 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.24 -22.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.611 2.364 . . . . 1.0 116.955 -169.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.15 64.06 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.47 1.033 . . . . 1.0 114.977 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.73 -10.7 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 N-CA-C 117.031 1.573 . . . . 1.0 117.031 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.3 p -70.74 172.05 9.42 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.722 1.761 . . . . 1.0 112.946 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.71 135.72 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.43 1.492 . . . . 1.0 109.88 -171.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.57 -37.02 77.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.15 54.27 3.09 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 127.206 2.203 . . . . 1.0 115.236 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.96 157.74 60.67 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.178 2.585 . . . . 1.0 112.543 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 125.758 1.623 . . . . 1.0 109.818 -178.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 114.843 0.697 . . . . 1.0 114.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -55.59 -30.68 61.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.149 1.38 . . . . 1.0 114.387 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.95 -27.12 68.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.76 -30.29 70.69 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.847 -1.158 . . . . 1.0 112.693 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.17 -14.59 50.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.871 0.868 . . . . 1.0 112.892 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.21 -14.41 7.04 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.97 41.33 1.06 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.402 1.477 . . . . 1.0 113.783 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 1.8 pp -47.36 -22.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.753 2.421 . . . . 1.0 117.057 -169.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.24 -16.19 66.58 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.478 1.037 . . . . 1.0 115.085 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.97 -8.52 0.1 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 117.053 1.581 . . . . 1.0 117.053 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -71.76 178.23 3.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.576 1.688 . . . . 1.0 113.027 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.71 134.03 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 1.0 109.737 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -38.52 89.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 36.05 56.42 2.91 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.637 1.975 . . . . 1.0 115.26 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.58 158.73 56.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.16 2.573 . . . . 1.0 112.571 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 126.042 1.737 . . . . 1.0 109.97 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.458 0.543 . . . . 1.0 114.458 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -56.79 -40.59 76.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.516 1.158 . . . . 1.0 112.697 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.76 -30.01 71.12 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.11 -30.57 69.36 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.202 -0.936 . . . . 1.0 112.757 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.92 -14.7 63.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.968 0.907 . . . . 1.0 113.126 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.64 -15.17 1.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.63 42.38 1.27 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.041 1.305 . . . . 1.0 113.106 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 pp -46.9 -26.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.063 2.545 . . . . 1.0 116.189 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.6 65.91 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.416 1.007 . . . . 1.0 115.286 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.52 -7.17 0.13 Allowed Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.888 1.515 . . . . 1.0 116.888 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -68.91 175.34 3.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.736 1.768 . . . . 1.0 113.13 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.24 130.35 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.783 1.633 . . . . 1.0 108.108 -170.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.45 -33.2 73.76 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 36.71 51.36 1.84 Allowed Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.847 2.059 . . . . 1.0 116.299 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.33 158.38 57.8 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.208 2.605 . . . . 1.0 112.731 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.726 1.61 . . . . 1.0 109.792 -179.72 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 114.715 0.646 . . . . 1.0 114.715 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p -55.78 -34.94 65.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.695 1.198 . . . . 1.0 113.859 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.71 -26.57 68.71 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.8 -30.35 70.0 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.048 -1.032 . . . . 1.0 112.799 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt -63.66 -15.09 57.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.706 0.802 . . . . 1.0 112.914 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -56.89 -15.95 5.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.6 39.75 1.1 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.148 1.356 . . . . 1.0 114.229 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.94 -26.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 127.505 2.322 . . . . 1.0 116.502 -169.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.18 -16.06 57.32 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.435 1.017 . . . . 1.0 115.411 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.75 -12.07 0.1 OUTLIER Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.754 1.462 . . . . 1.0 116.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.6 p -71.23 174.72 6.04 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.734 1.767 . . . . 1.0 112.795 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt -129.08 135.96 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.512 1.525 . . . . 1.0 109.771 -171.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.77 -37.0 77.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.21 54.24 3.14 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.067 2.147 . . . . 1.0 115.236 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.55 157.13 63.1 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.184 2.59 . . . . 1.0 112.579 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 125.748 1.619 . . . . 1.0 109.841 -178.751 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 N-CA-C 114.747 0.659 . . . . 1.0 114.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -55.8 -29.19 59.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.327 1.451 . . . . 1.0 114.456 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.92 -25.76 67.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.18 -31.76 72.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.353 -0.842 . . . . 1.0 112.643 169.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.24 -17.96 61.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.93 1.292 . . . . 1.0 112.518 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.74 -13.76 6.85 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 40.78 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.317 1.436 . . . . 1.0 114.063 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 1.7 pp -47.85 -22.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.712 2.405 . . . . 1.0 116.947 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.46 63.96 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.453 1.025 . . . . 1.0 115.04 170.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.3 -9.6 0.09 OUTLIER Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.064 1.586 . . . . 1.0 117.064 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.9 p -70.66 173.24 7.4 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.793 1.796 . . . . 1.0 113.112 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.01 137.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.717 1.607 . . . . 1.0 109.779 -171.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.5 -35.31 79.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 39.38 53.72 4.93 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 126.703 2.001 . . . . 1.0 115.057 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.63 156.56 65.54 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.034 2.489 . . . . 1.0 112.362 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 126.048 1.739 . . . . 1.0 110.083 -176.771 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 113.835 1.05 . . . . 1.0 113.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.202 0.816 . . . . 1.0 113.202 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' VAL . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.964 1.098 . . . . 1.0 113.964 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.806 0.669 . . . . 1.0 112.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 108.066 -1.087 . . . . 1.0 108.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.029 1.122 . . . . 1.0 114.029 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.048 0.758 . . . . 1.0 113.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 69' ' ' VAL . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.282 0.845 . . . . 1.0 113.282 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 69' ' ' VAL . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.71 1.374 . . . . 1.0 114.71 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.498 1.296 . . . . 1.0 114.498 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.924 0.713 . . . . 1.0 112.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 113.126 0.787 . . . . 1.0 113.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.914 0.709 . . . . 1.0 112.914 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.456 1.28 . . . . 1.0 114.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.412 0 N-CA-C 114.718 0.647 . . . . 1.0 114.718 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p -55.77 -35.29 66.07 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.894 1.278 . . . . 1.0 113.835 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.49 -26.12 68.57 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.19 -30.39 70.39 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.969 -1.082 . . . . 1.0 112.796 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.33 -14.92 61.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.32 1.048 . . . . 1.0 113.202 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -59.91 -15.24 20.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 45.83 1.64 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.573 1.558 . . . . 1.0 112.988 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 pp -49.92 -26.03 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 116.383 1.994 . . . . 1.0 116.383 -169.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.97 -5.65 88.88 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.773 1.178 . . . . 1.0 115.264 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.73 28.23 0.84 Allowed Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.749 1.274 . . . . 1.0 114.78 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -136.21 174.39 10.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.221 1.808 . . . . 1.0 111.538 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -130.24 138.4 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.572 1.549 . . . . 1.0 109.46 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' VAL . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -36.07 78.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 35.17 58.6 2.52 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.012 2.125 . . . . 1.0 114.64 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.88 161.88 43.78 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.32 2.68 . . . . 1.0 112.811 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.963 1.305 . . . . 1.0 113.338 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 N-CA-C 114.764 0.666 . . . . 1.0 114.764 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p -55.87 -39.52 71.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.922 1.289 . . . . 1.0 113.815 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -61.62 -22.92 65.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.2 -30.49 71.55 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.845 1.202 . . . . 1.0 112.606 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt -67.39 -13.51 62.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.47 1.108 . . . . 1.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.46 -15.53 7.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.22 40.11 1.23 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.213 1.387 . . . . 1.0 114.065 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.82 -26.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.367 2.267 . . . . 1.0 116.556 -169.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.23 -16.45 57.96 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 124.49 1.043 . . . . 1.0 115.356 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.81 -10.49 0.11 Allowed Glycine 0 CA--C 1.541 1.715 0 N-CA-C 116.875 1.51 . . . . 1.0 116.875 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.9 p -72.72 -179.97 3.34 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.568 1.684 . . . . 1.0 112.874 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -128.63 136.58 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.927 1.691 . . . . 1.0 109.608 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -38.63 91.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 35.71 56.88 2.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 126.553 1.941 . . . . 1.0 115.249 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.24 158.38 57.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.217 2.612 . . . . 1.0 112.649 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.149 1.78 . . . . 1.0 109.978 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.378 0 N-CA-C 114.704 0.642 . . . . 1.0 114.704 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -56.35 -29.54 61.51 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.945 1.298 . . . . 1.0 113.964 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -63.1 -26.54 68.88 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.09 -30.31 70.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.871 -1.143 . . . . 1.0 112.922 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.96 -14.96 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.893 0.877 . . . . 1.0 113.019 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.01 -13.39 4.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.67 39.52 1.3 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.136 1.351 . . . . 1.0 113.818 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -26.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 127.538 2.335 . . . . 1.0 116.51 -169.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.59 -16.34 55.26 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.424 1.012 . . . . 1.0 115.406 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.24 -11.34 0.09 OUTLIER Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.906 1.522 . . . . 1.0 116.906 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.37 175.09 5.71 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.757 1.779 . . . . 1.0 112.891 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.96 135.82 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.553 1.541 . . . . 1.0 109.737 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -38.59 91.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 37.16 56.53 3.74 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 125.884 1.673 . . . . 1.0 115.02 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.62 160.87 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.177 2.585 . . . . 1.0 112.828 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.808 1.243 . . . . 1.0 110.845 177.145 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.321 0 N-CA-C 114.801 0.68 . . . . 1.0 114.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p -56.9 -30.18 63.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.8 -26.51 68.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.64 -30.57 69.96 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.989 -1.069 . . . . 1.0 112.805 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.19 -14.96 61.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.932 0.893 . . . . 1.0 112.806 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.33 -17.34 7.49 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.62 40.11 1.12 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.292 1.425 . . . . 1.0 114.347 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.9 -26.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.469 2.307 . . . . 1.0 116.511 -169.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.03 -16.32 57.34 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.448 1.023 . . . . 1.0 115.325 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.14 -11.18 0.1 OUTLIER Glycine 0 CA--C 1.541 1.66 0 N-CA-C 116.861 1.505 . . . . 1.0 116.861 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -71.55 175.43 5.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.709 1.755 . . . . 1.0 112.801 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.03 136.58 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.506 1.522 . . . . 1.0 109.802 -171.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -37.33 77.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 38.79 55.98 5.26 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.179 1.792 . . . . 1.0 114.946 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -67.69 159.0 54.64 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.33 2.687 . . . . 1.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.059 1.744 . . . . 1.0 109.973 -177.434 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.481 0.553 . . . . 1.0 114.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p -56.72 -39.88 74.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.423 1.112 . . . . 1.0 112.719 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.07 -25.47 68.12 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.51 -30.45 71.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.951 -1.093 . . . . 1.0 112.328 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.81 -12.42 54.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.28 1.032 . . . . 1.0 112.954 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.37 -18.33 6.5 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.8 46.18 2.58 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.281 1.42 . . . . 1.0 112.409 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.11 -26.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.551 2.341 . . . . 1.0 116.366 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.92 -5.48 77.32 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.328 1.442 . . . . 1.0 115.239 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.83 28.6 2.01 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.066 1.793 . . . . 1.0 113.554 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.6 p -136.79 178.91 6.71 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.341 2.256 . . . . 1.0 110.72 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.87 124.94 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 1.0 108.514 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -60.64 -37.25 80.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 35.8 55.53 2.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 127.512 2.325 . . . . 1.0 115.291 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -68.55 157.26 62.55 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.148 2.566 . . . . 1.0 112.361 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 126.006 1.722 . . . . 1.0 110.067 -176.335 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.292 0 N-CA-C 114.748 0.659 . . . . 1.0 114.748 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p -56.09 -35.95 67.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.673 1.189 . . . . 1.0 113.304 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.05 -30.52 70.37 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.006 -1.059 . . . . 1.0 112.938 170.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.7 -14.75 61.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.769 0.828 . . . . 1.0 113.017 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -53.76 -21.57 7.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 46.08 1.65 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.118 1.342 . . . . 1.0 113.671 169.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -48.65 -26.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 127.187 2.195 . . . . 1.0 115.484 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.31 -5.38 76.05 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.376 1.465 . . . . 1.0 115.203 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.6 27.62 2.07 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.275 1.893 . . . . 1.0 113.575 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 p -136.18 178.86 6.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.369 2.267 . . . . 1.0 110.697 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt -128.91 124.81 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.25 1.42 . . . . 1.0 108.066 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -63.7 -35.84 81.88 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 35.21 52.03 1.42 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 127.153 2.181 . . . . 1.0 116.602 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -68.51 158.57 57.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.092 2.528 . . . . 1.0 112.738 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 126.059 1.744 . . . . 1.0 109.972 -177.521 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 N-CA-C 114.739 0.656 . . . . 1.0 114.739 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p -55.81 -33.92 64.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.817 1.247 . . . . 1.0 114.029 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.69 -29.69 70.69 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.63 -30.46 69.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.129 -0.982 . . . . 1.0 112.831 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.65 -20.54 64.91 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -49.76 -19.3 0.62 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.47 40.25 1.76 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.757 1.17 . . . . 1.0 113.206 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.11 -26.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 129.183 2.993 . . . . 1.0 116.426 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.82 -11.67 85.22 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.828 1.204 . . . . 1.0 115.208 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.48 0.28 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.097 1.332 . . . . 1.0 115.389 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.81 179.37 3.18 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.911 1.356 . . . . 1.0 111.93 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.59 133.36 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.422 1.489 . . . . 1.0 109.346 -172.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.26 -35.14 79.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 39.0 53.93 4.61 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 126.765 2.026 . . . . 1.0 115.025 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -68.16 157.91 59.74 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.15 2.567 . . . . 1.0 112.595 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.749 1.619 . . . . 1.0 109.785 -178.951 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 114.798 0.679 . . . . 1.0 114.798 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m -54.68 -35.75 63.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.948 1.299 . . . . 1.0 114.015 -175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.02 -22.18 66.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.02 -30.53 71.51 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.929 -1.107 . . . . 1.0 112.392 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt -66.06 -13.99 60.93 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.714 1.206 . . . . 1.0 113.048 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.64 -12.29 6.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.42 40.66 0.92 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.508 1.528 . . . . 1.0 114.067 169.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.35 -22.2 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 127.585 2.354 . . . . 1.0 116.951 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -16.77 62.95 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.419 1.009 . . . . 1.0 115.085 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.95 -9.98 0.09 OUTLIER Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.086 1.594 . . . . 1.0 117.086 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.14 172.36 9.34 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 119.802 1.801 . . . . 1.0 113.123 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt -129.42 138.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.693 1.597 . . . . 1.0 109.689 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 69' ' ' VAL . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -36.0 81.81 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 38.95 54.27 4.75 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 126.869 2.067 . . . . 1.0 114.776 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.72 159.33 53.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.417 2.745 . . . . 1.0 112.745 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.603 1.561 . . . . 1.0 110.435 -178.919 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 114.503 0.561 . . . . 1.0 114.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -57.17 -37.27 71.85 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.413 1.107 . . . . 1.0 112.84 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.03 -20.83 59.91 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.11 -38.23 90.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.24 -0.912 . . . . 1.0 112.373 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.08 -24.38 65.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.395 1.078 . . . . 1.0 112.191 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -59.77 -12.83 8.04 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.78 40.96 1.0 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.329 1.442 . . . . 1.0 113.887 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.252 1.8 pp -47.84 -22.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 127.823 2.449 . . . . 1.0 116.987 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.16 -16.48 64.59 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.419 1.009 . . . . 1.0 114.998 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.5 -10.57 0.1 OUTLIER Glycine 0 CA--C 1.541 1.684 0 N-CA-C 116.939 1.536 . . . . 1.0 116.939 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.0 p -71.15 173.24 7.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.77 1.785 . . . . 1.0 113.074 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt -129.53 140.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.793 1.637 . . . . 1.0 109.617 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -37.66 78.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 38.12 56.05 4.6 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.278 1.831 . . . . 1.0 115.083 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -68.15 159.81 51.53 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.232 2.622 . . . . 1.0 112.684 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.2 mm . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.575 1.15 . . . . 1.0 111.366 177.627 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.282 0 N-CA-C 114.641 0.616 . . . . 1.0 114.641 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -56.36 -29.82 61.87 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.936 1.294 . . . . 1.0 113.894 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.18 -23.92 67.65 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.27 -30.59 71.7 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.028 -1.045 . . . . 1.0 112.463 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt -67.63 -13.1 61.79 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.623 1.169 . . . . 1.0 113.282 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -58.3 -9.93 1.78 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.98 42.21 1.33 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.917 1.246 . . . . 1.0 113.067 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.17 -26.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.743 2.417 . . . . 1.0 116.407 -169.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.82 -15.29 62.1 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.506 1.051 . . . . 1.0 115.311 172.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.95 -9.86 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 N-CA-C 116.791 1.477 . . . . 1.0 116.791 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.3 p -69.42 173.13 6.18 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.697 1.749 . . . . 1.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm -128.36 127.78 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.52 1.528 . . . . 1.0 108.648 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 69' ' ' VAL . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.6 -35.25 80.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 38.99 53.63 4.45 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 126.886 2.074 . . . . 1.0 115.17 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.51 157.27 62.55 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.129 2.553 . . . . 1.0 112.356 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 125.986 1.714 . . . . 1.0 109.971 -176.604 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 N-CA-C 114.658 0.623 . . . . 1.0 114.658 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -56.96 -31.75 65.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.719 1.208 . . . . 1.0 113.675 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.44 -25.67 68.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.79 -30.53 70.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.941 -1.1 . . . . 1.0 112.842 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.49 -14.73 62.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.044 0.938 . . . . 1.0 112.992 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -50.62 -17.88 0.6 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.86 40.2 1.84 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.794 1.187 . . . . 1.0 113.006 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.04 -26.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 129.287 3.035 . . . . 1.0 116.45 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.56 85.44 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.87 1.224 . . . . 1.0 115.209 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.4 0.29 Allowed Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.18 1.372 . . . . 1.0 115.461 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -71.14 177.69 3.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.927 1.363 . . . . 1.0 111.931 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -128.76 130.11 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.092 1.357 . . . . 1.0 108.996 -173.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.63 -38.68 90.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 35.36 56.5 2.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.711 2.004 . . . . 1.0 115.394 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.83 158.37 58.13 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.07 2.513 . . . . 1.0 112.677 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.478 0.93 0 C-N-CA 125.779 1.632 . . . . 1.0 109.761 -179.311 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.335 0 N-CA-C 114.869 0.707 . . . . 1.0 114.869 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -54.61 -30.0 53.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.543 1.537 . . . . 1.0 114.71 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.18 -25.48 68.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.75 -30.47 70.8 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.869 -1.144 . . . . 1.0 112.603 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt -64.39 -13.69 52.29 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.022 0.929 . . . . 1.0 112.923 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.51 -14.71 5.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.8 39.56 1.12 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.218 1.39 . . . . 1.0 114.223 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.15 -26.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 127.486 2.314 . . . . 1.0 116.514 -169.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -16.22 55.82 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.413 1.006 . . . . 1.0 115.387 171.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.46 -12.36 0.1 OUTLIER Glycine 0 CA--C 1.54 1.639 0 N-CA-C 116.864 1.506 . . . . 1.0 116.864 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.0 p -71.51 174.32 6.79 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.679 1.74 . . . . 1.0 112.741 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.13 138.52 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.699 1.6 . . . . 1.0 109.519 -172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -88.91 -37.44 15.28 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 28.89 61.68 0.74 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.956 2.502 . . . . 1.0 115.251 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.93 163.17 39.41 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.378 2.719 . . . . 1.0 112.857 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.035 1.334 . . . . 1.0 113.394 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 114.817 0.687 . . . . 1.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p -53.69 -35.09 60.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 1.0 114.498 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.71 -20.85 62.1 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.55 -30.8 71.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.51 1.05 . . . . 1.0 113.017 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.7 -14.27 62.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.366 1.067 . . . . 1.0 112.358 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.23 -19.83 5.92 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 47.49 2.78 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.224 1.392 . . . . 1.0 112.574 169.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.57 -26.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 127.424 2.289 . . . . 1.0 115.829 -169.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.37 -5.48 79.32 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.254 1.406 . . . . 1.0 115.297 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.93 28.15 1.87 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.967 1.746 . . . . 1.0 113.705 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.7 p -136.56 179.2 6.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.248 2.219 . . . . 1.0 110.841 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.82 127.12 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.175 1.39 . . . . 1.0 108.717 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -37.08 74.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 38.29 56.2 4.81 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 126.33 1.852 . . . . 1.0 114.939 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.24 161.37 44.9 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.313 2.675 . . . . 1.0 112.801 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 125.675 1.59 . . . . 1.0 112.759 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.842 0.697 . . . . 1.0 114.842 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p -55.83 -33.72 64.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.817 1.247 . . . . 1.0 114.034 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.83 -23.99 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.97 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.774 1.17 . . . . 1.0 112.477 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.29 -14.37 61.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.322 1.049 . . . . 1.0 112.863 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -57.72 -15.58 8.37 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 40.95 0.8 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.686 1.612 . . . . 1.0 114.505 170.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.23 -22.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 127.568 2.347 . . . . 1.0 116.92 -169.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -16.58 62.54 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.398 0.999 . . . . 1.0 115.041 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.7 -10.52 0.09 OUTLIER Glycine 0 CA--C 1.542 1.729 0 N-CA-C 117.016 1.566 . . . . 1.0 117.016 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.05 171.91 10.06 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.755 1.777 . . . . 1.0 113.086 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.01 138.57 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.661 1.584 . . . . 1.0 109.729 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.55 -34.83 78.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 35.18 61.14 2.46 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.172 2.189 . . . . 1.0 114.787 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.38 146.52 40.82 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.539 2.826 . . . . 1.0 114.067 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.471 0.613 0 C-N-CA 126.162 1.785 . . . . 1.0 112.784 -177.423 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 N-CA-C 114.804 0.681 . . . . 1.0 114.804 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -55.42 -30.45 60.48 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.098 1.359 . . . . 1.0 114.098 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.66 -25.98 68.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.46 -30.31 70.51 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.921 -1.112 . . . . 1.0 112.68 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.91 -14.7 55.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.924 0.889 . . . . 1.0 112.923 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -58.33 -14.08 6.67 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.44 40.57 0.92 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.425 1.488 . . . . 1.0 114.01 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 pp -47.81 -22.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.746 2.419 . . . . 1.0 117.03 -169.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.79 -16.16 65.55 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.494 1.045 . . . . 1.0 115.068 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.76 -9.94 0.1 OUTLIER Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.984 1.554 . . . . 1.0 116.984 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -70.98 175.07 5.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.694 1.747 . . . . 1.0 112.995 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.71 136.43 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 1.0 109.574 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -38.25 87.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 36.28 56.3 3.04 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.551 1.94 . . . . 1.0 115.295 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.59 159.28 54.24 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.266 2.644 . . . . 1.0 112.656 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 125.709 1.604 . . . . 1.0 109.769 -179.375 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 114.486 0.555 . . . . 1.0 114.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p -57.3 -36.49 71.15 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.43 1.115 . . . . 1.0 112.924 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.27 -29.6 68.91 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.26 -30.04 70.22 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.205 -0.934 . . . . 1.0 112.775 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.07 -12.63 61.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.725 1.21 . . . . 1.0 113.556 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.42 -15.68 7.35 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.87 41.01 0.84 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.587 1.565 . . . . 1.0 114.414 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.24 -22.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.611 2.364 . . . . 1.0 116.955 -169.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.15 64.06 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.47 1.033 . . . . 1.0 114.977 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.73 -10.7 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 N-CA-C 117.031 1.573 . . . . 1.0 117.031 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.3 p -70.74 172.05 9.42 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.722 1.761 . . . . 1.0 112.946 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.71 135.72 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.43 1.492 . . . . 1.0 109.88 -171.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.57 -37.02 77.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.15 54.27 3.09 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 127.206 2.203 . . . . 1.0 115.236 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.96 157.74 60.67 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.178 2.585 . . . . 1.0 112.543 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 125.758 1.623 . . . . 1.0 109.818 -178.935 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 114.843 0.697 . . . . 1.0 114.843 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -55.59 -30.68 61.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.149 1.38 . . . . 1.0 114.387 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.95 -27.12 68.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.76 -30.29 70.69 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.847 -1.158 . . . . 1.0 112.693 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.17 -14.59 50.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.871 0.868 . . . . 1.0 112.892 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.21 -14.41 7.04 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.97 41.33 1.06 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.402 1.477 . . . . 1.0 113.783 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 1.8 pp -47.36 -22.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.753 2.421 . . . . 1.0 117.057 -169.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.24 -16.19 66.58 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.478 1.037 . . . . 1.0 115.085 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.97 -8.52 0.1 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 117.053 1.581 . . . . 1.0 117.053 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -71.76 178.23 3.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.576 1.688 . . . . 1.0 113.027 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.71 134.03 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 1.0 109.737 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -38.52 89.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 36.05 56.42 2.91 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.637 1.975 . . . . 1.0 115.26 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.58 158.73 56.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.16 2.573 . . . . 1.0 112.571 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 126.042 1.737 . . . . 1.0 109.97 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.458 0.543 . . . . 1.0 114.458 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -56.79 -40.59 76.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.516 1.158 . . . . 1.0 112.697 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.76 -30.01 71.12 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.11 -30.57 69.36 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.202 -0.936 . . . . 1.0 112.757 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.92 -14.7 63.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.968 0.907 . . . . 1.0 113.126 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.64 -15.17 1.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.63 42.38 1.27 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.041 1.305 . . . . 1.0 113.106 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 pp -46.9 -26.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.063 2.545 . . . . 1.0 116.189 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.6 65.91 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.416 1.007 . . . . 1.0 115.286 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.52 -7.17 0.13 Allowed Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.888 1.515 . . . . 1.0 116.888 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -68.91 175.34 3.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.736 1.768 . . . . 1.0 113.13 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.24 130.35 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.783 1.633 . . . . 1.0 108.108 -170.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.45 -33.2 73.76 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 36.71 51.36 1.84 Allowed Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.847 2.059 . . . . 1.0 116.299 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.33 158.38 57.8 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.208 2.605 . . . . 1.0 112.731 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.726 1.61 . . . . 1.0 109.792 -179.72 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 114.715 0.646 . . . . 1.0 114.715 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p -55.78 -34.94 65.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.695 1.198 . . . . 1.0 113.859 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.71 -26.57 68.71 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.8 -30.35 70.0 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.048 -1.032 . . . . 1.0 112.799 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt -63.66 -15.09 57.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.706 0.802 . . . . 1.0 112.914 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -56.89 -15.95 5.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.6 39.75 1.1 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.148 1.356 . . . . 1.0 114.229 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.94 -26.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 127.505 2.322 . . . . 1.0 116.502 -169.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.18 -16.06 57.32 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.435 1.017 . . . . 1.0 115.411 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.75 -12.07 0.1 OUTLIER Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.754 1.462 . . . . 1.0 116.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.6 p -71.23 174.72 6.04 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.734 1.767 . . . . 1.0 112.795 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt -129.08 135.96 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.512 1.525 . . . . 1.0 109.771 -171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.77 -37.0 77.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.21 54.24 3.14 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.067 2.147 . . . . 1.0 115.236 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.55 157.13 63.1 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.184 2.59 . . . . 1.0 112.579 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 125.748 1.619 . . . . 1.0 109.841 -178.751 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 N-CA-C 114.747 0.659 . . . . 1.0 114.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -55.8 -29.19 59.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.327 1.451 . . . . 1.0 114.456 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.92 -25.76 67.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.18 -31.76 72.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.353 -0.842 . . . . 1.0 112.643 169.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.24 -17.96 61.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.93 1.292 . . . . 1.0 112.518 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.74 -13.76 6.85 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 40.78 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.317 1.436 . . . . 1.0 114.063 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 1.7 pp -47.85 -22.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.712 2.405 . . . . 1.0 116.947 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.46 63.96 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.453 1.025 . . . . 1.0 115.04 170.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.3 -9.6 0.09 OUTLIER Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.064 1.586 . . . . 1.0 117.064 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.9 p -70.66 173.24 7.4 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.793 1.796 . . . . 1.0 113.112 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.01 137.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.717 1.607 . . . . 1.0 109.779 -171.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.5 -35.31 79.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 39.38 53.72 4.93 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 126.703 2.001 . . . . 1.0 115.057 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.63 156.56 65.54 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.034 2.489 . . . . 1.0 112.362 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 126.048 1.739 . . . . 1.0 110.083 -176.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 113.835 1.05 . . . . 1.0 113.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 113.202 0.816 . . . . 1.0 113.202 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' VAL . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 113.815 1.043 . . . . 1.0 113.815 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 109.608 -0.515 . . . . 1.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.964 1.098 . . . . 1.0 113.964 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 . . . . . 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 113.019 0.748 . . . . 1.0 113.019 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.806 0.669 . . . . 1.0 112.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.954 0.724 . . . . 1.0 112.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 108.514 -0.921 . . . . 1.0 108.514 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 . . . . . 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 113.017 0.747 . . . . 1.0 113.017 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 108.066 -1.087 . . . . 1.0 108.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 114.029 1.122 . . . . 1.0 114.029 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.048 0.758 . . . . 1.0 113.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.689 -0.485 . . . . 1.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 69' ' ' VAL . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 112.84 0.681 . . . . 1.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 113.894 1.072 . . . . 1.0 113.894 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.282 0.845 . . . . 1.0 113.282 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 69' ' ' VAL . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 113.675 0.991 . . . . 1.0 113.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.71 1.374 . . . . 1.0 114.71 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 114.498 1.296 . . . . 1.0 114.498 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.717 -0.846 . . . . 1.0 108.717 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.863 0.69 . . . . 1.0 112.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 . . . . . 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 114.098 1.147 . . . . 1.0 114.098 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.924 0.713 . . . . 1.0 112.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 113.556 0.947 . . . . 1.0 113.556 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 114.387 1.254 . . . . 1.0 114.387 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 112.892 0.701 . . . . 1.0 112.892 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 112.697 0.628 . . . . 1.0 112.697 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 113.126 0.787 . . . . 1.0 113.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.914 0.709 . . . . 1.0 112.914 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 114.456 1.28 . . . . 1.0 114.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.412 0 N-CA-C 114.718 0.647 . . . . 1.0 114.718 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.2 p -55.77 -35.29 66.07 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.894 1.278 . . . . 1.0 113.835 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -61.5 -33.3 73.56 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.242 0.83 . . . . 1.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.1 ttt -73.09 -35.84 66.69 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.523 -0.736 . . . . 1.0 111.833 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.41 -40.98 85.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.418 0.687 . . . . 1.0 111.628 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.88 -43.8 97.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.861 0.864 . . . . 1.0 111.788 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.35 -41.2 93.15 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.815 -0.553 . . . . 1.0 111.84 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.8 m -64.81 -39.01 92.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.812 0.845 . . . . 1.0 112.389 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.66 88.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.491 0.717 . . . . 1.0 112.431 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.33 -40.78 94.12 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.356 -0.84 . . . . 1.0 112.539 174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.32 -35.27 79.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.329 -0.857 . . . . 1.0 112.499 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.3 m -65.88 -38.62 89.27 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.511 -0.743 . . . . 1.0 111.759 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.69 -39.07 84.44 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.334 -0.854 . . . . 1.0 111.363 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.16 -37.8 84.2 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.354 -0.841 . . . . 1.0 112.312 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -66.45 -41.98 88.31 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.408 -0.808 . . . . 1.0 112.81 171.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -60.42 -39.44 87.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.909 0.884 . . . . 1.0 112.336 172.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.16 -42.72 83.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.694 0.797 . . . . 1.0 112.256 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.49 -26.12 68.57 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.527 1.058 . . . . 1.0 113.444 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -61.19 -30.39 70.39 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 120.969 -1.082 . . . . 1.0 112.796 169.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt -65.33 -14.92 61.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.32 1.048 . . . . 1.0 113.202 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -56.15 -26.41 50.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.71 1.204 . . . . 1.0 113.138 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.76 13.49 52.76 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.339 0.971 . . . . 1.0 115.09 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.8 mtt85 -130.74 159.34 37.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.969 1.385 . . . . 1.0 113.171 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.94 158.85 25.1 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 1.0 110.339 170.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.04 -174.74 13.94 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.759 2.123 . . . . 1.0 113.175 174.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -145.39 114.32 6.92 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.318 2.247 . . . . 1.0 110.104 -169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.7 t -74.55 134.27 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.304 1.042 . . . . 1.0 110.907 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 -10.76 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.007 1.323 . . . . 1.0 113.951 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.5 m -137.41 127.49 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.742 -1.577 . . . . 1.0 106.742 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.17 142.39 31.28 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -169.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.6 t -123.14 92.36 49.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 126.294 1.838 . . . . 1.0 108.107 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.63 173.49 13.82 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.021 1.814 . . . . 1.0 112.058 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -56.89 -14.76 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 115.987 1.847 . . . . 1.0 115.987 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -145.8 23.45 1.4 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.49 1.916 . . . . 1.0 112.316 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -132.34 -168.13 11.96 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.722 1.153 . . . . 1.0 114.995 -169.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.82 145.49 51.18 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.371 1.468 . . . . 1.0 111.592 -172.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.62 -145.45 4.13 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.28 1.895 . . . . 1.0 110.701 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -140.54 149.53 42.55 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.477 1.139 . . . . 1.0 112.59 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -143.91 157.41 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.415 1.886 . . . . 1.0 111.25 -175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.86 147.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 126.598 1.959 . . . . 1.0 108.079 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.58 152.19 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.725 1.148 . . . . 1.0 109.748 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -59.91 -15.24 20.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.71 45.83 1.64 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.573 1.558 . . . . 1.0 112.988 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 pp -49.92 -26.03 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 116.383 1.994 . . . . 1.0 116.383 -169.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.97 -5.65 88.88 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.773 1.178 . . . . 1.0 115.264 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.73 28.23 0.84 Allowed Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.749 1.274 . . . . 1.0 114.78 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.4 p -136.21 174.39 10.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.221 1.808 . . . . 1.0 111.538 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -130.24 138.4 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.572 1.549 . . . . 1.0 109.46 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.7 p -69.05 149.16 49.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.173 0.989 . . . . 1.0 113.046 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -141.93 158.87 43.27 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.204 1.802 . . . . 1.0 110.609 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.8 m -65.76 150.71 48.08 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.869 0.366 . . . . 1.0 111.269 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.36 146.17 38.07 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.2 154.18 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 126.079 1.752 . . . . 1.0 112.083 174.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.3 p -84.45 92.21 8.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.948 1.699 . . . . 1.0 112.366 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.03 -36.46 70.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -100.81 18.6 19.04 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.069 1.348 . . . . 1.0 112.654 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.0 m120 49.23 47.03 22.6 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.914 1.686 . . . . 1.0 113.283 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -108.35 152.79 24.17 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.875 1.27 . . . . 1.0 110.893 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.8 124.26 32.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 171.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.51 91.83 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.318 1.447 . . . . 1.0 109.352 -171.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.9 m -68.55 169.36 11.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.531 1.132 . . . . 1.0 113.39 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.79 142.31 11.66 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.992 1.317 . . . . 1.0 112.262 169.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.94 44.59 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 115.989 1.156 . . . . 1.0 115.989 169.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.9 t -127.45 154.05 45.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.89 1.345 . . . . 1.0 111.665 172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 32.3 m -94.37 128.16 40.72 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 1.0 109.672 -175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.7 m -127.31 145.45 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.449 1.5 . . . . 1.0 111.263 -169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.3 tp -92.93 128.15 38.69 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 169.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.0 t -79.87 75.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.319 1.048 . . . . 1.0 110.356 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 69' ' ' VAL . 3.2 m -68.33 -23.31 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.901 1.68 . . . . 1.0 115.244 -170.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -147.94 165.16 31.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.176 0.99 . . . . 1.0 109.763 170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.16 139.11 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 O-C-N 121.173 -0.954 . . . . 1.0 110.751 -175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.95 161.4 35.36 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.235 2.214 . . . . 1.0 108.295 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -50.21 99.18 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.285 1.434 . . . . 1.0 114.146 -172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.76 10.98 59.56 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.458 1.504 . . . . 1.0 115.692 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.04 85.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.868 2.067 . . . . 1.0 108.465 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -74.44 146.73 42.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.303 1.441 . . . . 1.0 110.203 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -109.48 120.54 42.81 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.71 163.12 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 112.799 0.666 . . . . 1.0 112.799 -169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -150.46 141.93 15.16 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.212 1.405 . . . . 1.0 109.679 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.43 94.84 0.59 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.248 2.632 . . . . 1.0 112.994 -174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -36.07 78.66 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.075 0.95 . . . . 1.0 111.309 172.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 35.17 58.6 2.52 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 127.012 2.125 . . . . 1.0 114.64 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -68.88 161.88 43.78 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.32 2.68 . . . . 1.0 112.811 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.963 1.305 . . . . 1.0 113.338 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.306 0 N-CA-C 114.764 0.666 . . . . 1.0 114.764 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 p -55.87 -39.52 71.64 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.922 1.289 . . . . 1.0 113.815 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -61.78 -37.93 86.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.712 0.805 . . . . 1.0 112.695 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -73.13 -36.32 66.69 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.242 1.017 . . . . 1.0 111.731 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -43.45 88.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.696 0.798 . . . . 1.0 111.875 173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.49 -37.79 87.85 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.5 -0.75 . . . . 1.0 112.355 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.6 m -63.01 -42.18 99.75 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.647 -0.658 . . . . 1.0 111.692 172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.1 m -64.4 -38.47 91.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.663 0.785 . . . . 1.0 112.379 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.37 -42.14 93.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.561 0.744 . . . . 1.0 112.273 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.87 -41.43 95.67 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.349 -0.845 . . . . 1.0 112.145 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -65.04 -35.37 80.97 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.277 -0.889 . . . . 1.0 112.532 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.8 m -66.56 -38.47 87.15 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.546 -0.721 . . . . 1.0 111.832 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.71 -39.81 84.31 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.498 -0.751 . . . . 1.0 111.095 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.73 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.27 -0.894 . . . . 1.0 112.178 173.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -64.24 -39.01 93.07 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.454 -0.779 . . . . 1.0 112.781 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -65.41 -41.52 93.51 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.425 -0.797 . . . . 1.0 112.287 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.9 -36.78 82.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.238 1.015 . . . . 1.0 111.85 175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -61.62 -22.92 65.68 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.59 0.959 . . . . 1.0 113.59 174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.2 -30.49 71.55 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.845 1.202 . . . . 1.0 112.606 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.4 mt -67.39 -13.51 62.08 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.47 1.108 . . . . 1.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -65.09 -8.35 16.21 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.225 1.41 . . . . 1.0 113.534 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.07 18.92 41.81 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.16 1.362 . . . . 1.0 113.556 170.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.24 159.52 37.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.898 1.279 . . . . 1.0 113.555 -171.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.65 150.69 20.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.022 2.129 . . . . 1.0 109.557 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.26 -174.67 15.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.228 1.87 . . . . 1.0 114.143 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -144.5 116.15 8.17 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 127.434 2.294 . . . . 1.0 109.582 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -73.95 134.2 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.802 0.841 . . . . 1.0 111.122 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -13.56 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.802 1.641 . . . . 1.0 113.467 -172.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.8 m -140.78 127.08 19.79 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 105.846 -1.909 . . . . 1.0 105.846 169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.7 141.94 42.04 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.896 0.878 . . . . 1.0 113.273 -169.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.45 94.21 48.13 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.729 1.611 . . . . 1.0 107.753 -173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.22 170.19 19.72 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.189 1.926 . . . . 1.0 112.52 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.18 -22.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 115.365 1.617 . . . . 1.0 115.365 -169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -141.29 24.41 2.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.699 2.0 . . . . 1.0 112.425 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.88 -161.17 8.59 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.495 1.045 . . . . 1.0 114.62 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -128.69 145.75 51.07 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.997 1.319 . . . . 1.0 112.784 -169.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.06 -143.39 3.81 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.927 2.203 . . . . 1.0 110.173 170.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -144.2 155.35 43.86 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 118.506 1.153 . . . . 1.0 112.974 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.04 158.29 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.571 1.948 . . . . 1.0 111.704 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.77 145.39 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 126.45 1.9 . . . . 1.0 108.484 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.0 mm -71.65 148.06 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.616 1.098 . . . . 1.0 109.511 169.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -57.46 -15.53 7.13 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.575 2.065 . . . . 1.0 116.575 -169.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.22 40.11 1.23 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.213 1.387 . . . . 1.0 114.065 169.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.82 -26.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 127.367 2.267 . . . . 1.0 116.556 -169.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.23 -16.45 57.96 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 124.49 1.043 . . . . 1.0 115.356 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.81 -10.49 0.11 Allowed Glycine 0 CA--C 1.541 1.715 0 N-CA-C 116.875 1.51 . . . . 1.0 116.875 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.9 p -72.72 -179.97 3.34 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 119.568 1.684 . . . . 1.0 112.874 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 mm -128.63 136.58 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.927 1.691 . . . . 1.0 109.608 -170.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.8 p -73.12 146.26 45.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 1.0 112.451 174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -142.16 160.64 39.82 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.016 1.727 . . . . 1.0 110.95 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.2 t -68.65 150.72 47.62 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.989 0.516 . . . . 1.0 110.254 169.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.61 147.16 37.16 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.17 154.25 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.992 2.117 . . . . 1.0 110.507 171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.7 t -79.18 123.66 27.6 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.369 -0.832 . . . . 1.0 110.978 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.73 -11.37 59.87 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.398 1.079 . . . . 1.0 113.07 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -126.49 19.45 7.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.453 1.501 . . . . 1.0 112.511 -169.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.257 0.9 OUTLIER 44.92 41.06 4.9 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.168 2.187 . . . . 1.0 114.764 -175.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -96.18 156.58 16.27 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.137 1.375 . . . . 1.0 111.636 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -96.28 82.82 3.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.327 1.051 . . . . 1.0 109.032 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -80.07 97.54 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.136 1.374 . . . . 1.0 109.495 -169.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.41 170.03 12.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.701 0.801 . . . . 1.0 113.06 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -53.57 142.79 21.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.425 1.49 . . . . 1.0 112.748 172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.12 32.17 60.78 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 115.738 1.055 . . . . 1.0 115.738 169.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 t -120.29 154.2 35.31 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.149 1.474 . . . . 1.0 112.424 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 52.7 m -93.71 123.45 37.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 1.0 110.136 -171.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.3 m -127.83 145.53 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.052 1.341 . . . . 1.0 112.361 -169.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.5 tp -94.61 127.54 40.64 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -75.78 123.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 108.273 -1.01 . . . . 1.0 108.273 169.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.85 -20.06 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.595 1.158 . . . . 1.0 113.72 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -151.11 162.67 40.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.457 1.503 . . . . 1.0 108.703 169.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.2 mt -148.89 137.05 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.998 -1.064 . . . . 1.0 110.575 -170.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.51 84.7 1.87 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.308 1.443 . . . . 1.0 111.673 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 56.1 t30 41.82 52.99 4.12 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 126.577 1.951 . . . . 1.0 115.689 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.05 -9.73 50.94 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.409 1.48 . . . . 1.0 114.338 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.9 t -113.43 98.64 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.16 1.784 . . . . 1.0 108.39 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -80.59 147.54 30.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.812 1.245 . . . . 1.0 110.14 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.3 m -108.75 120.78 43.48 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.859 1.264 . . . . 1.0 107.798 172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.45 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.245 0.618 . . . . 1.0 112.399 -169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.8 t -143.39 140.78 18.0 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 124.443 1.097 . . . . 1.0 110.375 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.0 90.3 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.518 2.812 . . . . 1.0 112.68 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.22 -38.63 91.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.924 1.29 . . . . 1.0 111.866 176.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 35.71 56.88 2.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 126.553 1.941 . . . . 1.0 115.249 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.24 158.38 57.77 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.217 2.612 . . . . 1.0 112.649 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 mm . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.149 1.78 . . . . 1.0 109.978 -177.053 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.378 0 N-CA-C 114.704 0.642 . . . . 1.0 114.704 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -56.35 -29.54 61.51 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.945 1.298 . . . . 1.0 113.964 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -59.47 -31.3 69.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.323 1.049 . . . . 1.0 113.562 173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 mmt -72.67 -36.52 67.94 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.208 0.913 . . . . 1.0 111.972 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.42 -40.75 77.07 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.966 0.906 . . . . 1.0 111.283 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.22 -43.64 97.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.255 1.022 . . . . 1.0 111.889 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.7 m -60.52 -41.1 93.71 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.705 -0.622 . . . . 1.0 111.87 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.8 m -64.4 -39.81 94.58 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.577 0.751 . . . . 1.0 112.383 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.52 90.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.429 0.692 . . . . 1.0 112.497 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.75 -40.2 91.84 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.425 -0.797 . . . . 1.0 112.599 175.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.53 -34.86 77.94 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.236 -0.915 . . . . 1.0 112.596 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 -41.51 96.46 Favored 'General case' 0 N--CA 1.469 0.475 0 O-C-N 121.606 -0.683 . . . . 1.0 111.318 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.52 -38.35 86.99 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.217 -0.927 . . . . 1.0 111.531 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.17 92.99 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.33 -0.856 . . . . 1.0 112.102 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -65.17 -41.54 94.54 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.512 -0.742 . . . . 1.0 112.825 172.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -60.33 -40.01 89.13 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.009 0.924 . . . . 1.0 112.153 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.27 -41.57 85.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.563 0.745 . . . . 1.0 112.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -63.1 -26.54 68.88 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.595 1.089 . . . . 1.0 113.452 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -61.09 -30.31 70.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.871 -1.143 . . . . 1.0 112.922 169.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 25.2 mt -64.96 -14.96 61.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.893 0.877 . . . . 1.0 113.019 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -64.62 -7.64 11.26 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.158 1.383 . . . . 1.0 113.746 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.6 19.49 36.21 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.117 1.341 . . . . 1.0 113.628 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -130.82 159.54 37.04 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.818 1.247 . . . . 1.0 113.662 -171.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 tp -97.64 149.1 22.62 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.023 2.129 . . . . 1.0 109.647 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.52 15.27 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 126.189 1.852 . . . . 1.0 113.988 -175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -145.31 116.77 8.04 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 127.146 2.178 . . . . 1.0 109.52 -170.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -74.61 134.12 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.088 0.955 . . . . 1.0 111.339 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 -10.11 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 126.284 1.834 . . . . 1.0 113.409 -172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.6 m -143.58 126.13 15.9 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 105.528 -2.027 . . . . 1.0 105.528 169.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.07 139.6 46.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.967 0.907 . . . . 1.0 113.408 -169.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.5 t -117.59 96.53 49.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 125.895 1.678 . . . . 1.0 108.322 -176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.51 173.35 14.64 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.146 1.897 . . . . 1.0 112.718 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 m -54.26 -25.71 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.075 1.75 . . . . 1.0 115.664 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -141.03 24.44 2.16 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.427 1.891 . . . . 1.0 112.174 -177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.55 -164.87 10.52 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.745 1.164 . . . . 1.0 114.252 -172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -128.72 145.55 51.14 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.855 1.262 . . . . 1.0 112.228 -169.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.08 -144.5 3.95 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.798 2.142 . . . . 1.0 110.052 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -143.74 155.0 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.495 1.147 . . . . 1.0 113.118 -174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.91 158.11 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.524 1.93 . . . . 1.0 111.733 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.8 145.18 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 126.137 1.775 . . . . 1.0 108.145 169.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.0 mm -71.73 147.68 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.396 0.998 . . . . 1.0 109.448 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.01 -13.39 4.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.695 2.109 . . . . 1.0 116.695 -169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.67 39.52 1.3 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.136 1.351 . . . . 1.0 113.818 169.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -26.3 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 127.538 2.335 . . . . 1.0 116.51 -169.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.59 -16.34 55.26 Favored Glycine 0 CA--C 1.543 1.796 0 C-N-CA 124.424 1.012 . . . . 1.0 115.406 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.24 -11.34 0.09 OUTLIER Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.906 1.522 . . . . 1.0 116.906 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.37 175.09 5.71 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.757 1.779 . . . . 1.0 112.891 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.96 135.82 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.553 1.541 . . . . 1.0 109.737 -171.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.719 1.208 . . . . 1.0 113.033 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.16 161.28 38.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.362 1.865 . . . . 1.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.6 m -74.21 155.69 38.06 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.032 -0.418 . . . . 1.0 110.02 169.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.09 150.26 37.86 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.072 1.138 . . . . 1.0 114.072 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.28 156.7 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 127.103 2.161 . . . . 1.0 111.311 172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -75.85 119.75 20.27 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 121.557 -0.714 . . . . 1.0 111.184 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -73.18 -30.51 63.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.996 0.918 . . . . 1.0 112.596 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -105.39 10.2 33.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.44 1.496 . . . . 1.0 114.319 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.28 47.91 21.97 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.088 1.755 . . . . 1.0 112.302 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -131.66 156.48 45.79 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.732 1.613 . . . . 1.0 111.088 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -80.9 132.93 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -125.47 83.89 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 125.232 1.413 . . . . 1.0 108.021 -174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.7 m -65.94 167.27 9.94 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.791 1.236 . . . . 1.0 112.995 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -51.37 140.47 17.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.031 1.333 . . . . 1.0 113.438 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.29 32.32 58.25 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.586 0.995 . . . . 1.0 115.586 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 t -119.55 152.39 37.07 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.891 1.345 . . . . 1.0 111.83 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.4 m -93.34 126.41 38.45 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.807 1.243 . . . . 1.0 110.068 -173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.67 145.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.545 1.538 . . . . 1.0 112.77 -169.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.8 tp -95.26 127.78 41.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.146 -1.057 . . . . 1.0 108.146 169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 t -74.85 126.66 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.837 -1.172 . . . . 1.0 107.837 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.77 -21.16 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.546 1.138 . . . . 1.0 114.003 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.3 162.59 40.22 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.454 1.502 . . . . 1.0 107.939 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.09 141.15 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 120.834 -1.166 . . . . 1.0 110.837 -171.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -134.34 160.96 36.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.307 2.243 . . . . 1.0 108.204 169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -50.33 98.76 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.498 1.519 . . . . 1.0 113.784 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.66 8.43 60.24 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.702 1.62 . . . . 1.0 115.923 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.4 t -131.99 86.82 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 127.034 2.134 . . . . 1.0 108.711 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.62 149.98 39.81 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.854 1.262 . . . . 1.0 110.561 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -108.5 120.25 41.89 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.943 1.297 . . . . 1.0 108.375 172.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.98 161.73 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.308 0.643 . . . . 1.0 112.696 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -141.16 139.53 19.37 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.037 1.335 . . . . 1.0 110.142 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.65 92.36 0.69 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.362 2.708 . . . . 1.0 112.632 -177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -38.59 91.67 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.832 1.253 . . . . 1.0 112.139 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 37.16 56.53 3.74 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 125.884 1.673 . . . . 1.0 115.02 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.62 160.87 47.61 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.177 2.585 . . . . 1.0 112.828 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 124.808 1.243 . . . . 1.0 110.845 177.145 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.321 0 N-CA-C 114.801 0.68 . . . . 1.0 114.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.6 p -56.9 -30.18 63.7 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.856 1.428 . . . . 1.0 114.856 -173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -63.46 -31.55 72.75 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.914 -1.116 . . . . 1.0 113.25 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -74.11 -11.28 60.26 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.822 0.849 . . . . 1.0 113.238 172.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 63.2 mt -93.92 -28.26 15.92 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.001 1.321 . . . . 1.0 111.316 170.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -68.0 -43.31 79.18 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.027 -1.045 . . . . 1.0 111.664 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.0 p -64.33 -38.72 92.02 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.53 -0.731 . . . . 1.0 112.731 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.1 p -67.63 -36.67 81.22 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.087 0.773 . . . . 1.0 113.087 172.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.36 92.27 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.069 0.85 . . . . 1.0 112.406 173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -66.95 -37.32 84.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.305 -0.872 . . . . 1.0 112.638 174.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.71 -40.35 96.54 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.321 -0.862 . . . . 1.0 112.049 171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.9 m -63.72 -37.92 89.18 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.601 -0.687 . . . . 1.0 111.809 173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.21 -38.64 85.64 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.486 -0.759 . . . . 1.0 111.432 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -37.98 85.19 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.308 -0.87 . . . . 1.0 112.304 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -67.6 -38.78 84.47 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.325 -0.859 . . . . 1.0 112.883 172.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -62.25 -39.38 92.66 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.757 0.823 . . . . 1.0 112.24 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -67.08 -41.64 86.01 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.45 0.7 . . . . 1.0 112.004 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.8 -26.51 68.66 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.495 1.043 . . . . 1.0 113.451 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.64 -30.57 69.96 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.989 -1.069 . . . . 1.0 112.805 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.1 mt -65.19 -14.96 61.87 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.932 0.893 . . . . 1.0 112.806 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.8 ttm180 -63.05 -10.15 13.05 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.806 1.243 . . . . 1.0 113.611 171.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.06 17.88 55.43 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.884 1.231 . . . . 1.0 113.991 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -133.93 159.21 41.4 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 118.839 1.319 . . . . 1.0 113.77 -169.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.6 157.44 19.12 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.397 1.079 . . . . 1.0 110.305 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.48 -172.96 14.04 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.342 1.925 . . . . 1.0 113.78 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.92 116.01 8.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.728 2.411 . . . . 1.0 109.618 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.5 t -74.54 131.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.815 0.846 . . . . 1.0 111.367 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -122.53 -11.98 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 126.423 1.889 . . . . 1.0 113.466 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.0 m -142.48 125.96 16.74 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 169.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 141.13 35.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.705 1.002 . . . . 1.0 113.705 -169.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 38.6 t -120.16 93.52 48.06 Favored Pre-proline 0 N--CA 1.47 0.538 0 C-N-CA 125.972 1.709 . . . . 1.0 108.254 -175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -75.63 174.48 12.74 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.23 1.954 . . . . 1.0 112.577 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -54.56 -26.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 115.724 1.75 . . . . 1.0 115.724 -169.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -143.26 31.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.708 1.603 . . . . 1.0 111.242 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.54 -167.14 10.97 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.694 1.14 . . . . 1.0 114.298 -174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -128.57 145.6 51.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.949 1.3 . . . . 1.0 111.821 -169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.32 -144.58 3.95 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.6 2.047 . . . . 1.0 110.159 172.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -143.73 154.66 43.7 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.214 1.007 . . . . 1.0 112.911 -174.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -145.25 157.57 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.586 1.954 . . . . 1.0 111.468 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.87 145.18 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.092 1.757 . . . . 1.0 108.297 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.8 mm -71.59 149.13 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.715 1.143 . . . . 1.0 110.084 171.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.33 -17.34 7.49 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 116.457 2.021 . . . . 1.0 116.457 -169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.62 40.11 1.12 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.292 1.425 . . . . 1.0 114.347 170.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.9 -26.38 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.469 2.307 . . . . 1.0 116.511 -169.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.03 -16.32 57.34 Favored Glycine 0 CA--C 1.542 1.76 0 C-N-CA 124.448 1.023 . . . . 1.0 115.325 171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.14 -11.18 0.1 OUTLIER Glycine 0 CA--C 1.541 1.66 0 N-CA-C 116.861 1.505 . . . . 1.0 116.861 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -71.55 175.43 5.58 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.709 1.755 . . . . 1.0 112.801 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.2 mt -129.03 136.58 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.506 1.522 . . . . 1.0 109.802 -171.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -66.55 149.47 50.41 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.695 1.198 . . . . 1.0 112.928 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -142.47 159.96 41.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.156 1.782 . . . . 1.0 111.1 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -71.31 152.11 43.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.26 0.624 . . . . 1.0 110.332 169.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.18 146.55 33.79 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.843 1.053 . . . . 1.0 113.843 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.0 m -129.24 156.71 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 126.805 2.042 . . . . 1.0 111.565 171.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.8 t -81.08 111.34 17.44 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.565 -0.709 . . . . 1.0 111.453 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -65.45 -34.79 79.12 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.057 0.943 . . . . 1.0 112.596 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.36 9.22 42.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.815 1.246 . . . . 1.0 113.482 -169.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.24 46.3 24.0 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.575 1.55 . . . . 1.0 112.194 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -131.47 152.66 50.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.54 1.536 . . . . 1.0 111.238 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.93 136.23 37.2 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.802 -0.561 . . . . 1.0 110.064 -176.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -128.96 86.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.823 1.249 . . . . 1.0 108.717 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.4 m -65.89 167.36 9.7 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.543 1.137 . . . . 1.0 112.554 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -52.14 141.93 17.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.975 1.31 . . . . 1.0 113.445 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.23 40.65 33.42 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 116.15 1.22 . . . . 1.0 116.15 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 t -129.3 157.55 41.58 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 118.88 1.34 . . . . 1.0 112.428 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 m -93.69 125.08 38.11 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.017 0.927 . . . . 1.0 110.538 -176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.08 145.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.276 1.43 . . . . 1.0 110.882 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.8 tp -94.07 126.42 39.29 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.2 t -74.27 121.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.22 -18.79 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.769 1.228 . . . . 1.0 113.458 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -149.75 160.13 43.79 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.138 1.375 . . . . 1.0 108.897 168.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.7 mt -147.74 131.82 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.126 0.97 . . . . 1.0 110.029 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -145.83 97.69 3.0 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.13 0.972 . . . . 1.0 112.506 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 45.92 40.06 6.29 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 115.998 1.851 . . . . 1.0 115.998 169.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.99 -10.33 51.68 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.984 1.278 . . . . 1.0 114.786 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.48 101.0 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.917 1.687 . . . . 1.0 108.39 172.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.99 147.91 34.65 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.658 1.183 . . . . 1.0 109.933 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -108.78 121.63 45.47 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.527 -1.286 . . . . 1.0 107.527 169.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.8 162.72 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.602 0.761 . . . . 1.0 112.431 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.3 t -144.46 141.14 17.46 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.593 1.157 . . . . 1.0 110.26 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.38 91.22 0.67 Allowed 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.339 2.693 . . . . 1.0 112.453 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -37.33 77.8 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.322 1.049 . . . . 1.0 111.625 177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 38.79 55.98 5.26 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.179 1.792 . . . . 1.0 114.946 -175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -67.69 159.0 54.64 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.33 2.687 . . . . 1.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.059 1.744 . . . . 1.0 109.973 -177.434 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.481 0.553 . . . . 1.0 114.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.2 p -56.72 -39.88 74.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.423 1.112 . . . . 1.0 112.719 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -57.88 -36.4 72.32 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.098 1.359 . . . . 1.0 113.399 172.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -75.28 -37.78 60.71 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.446 -0.783 . . . . 1.0 111.813 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.8 mt -63.02 -42.28 99.75 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.69 -0.631 . . . . 1.0 111.69 172.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.5 -39.87 94.58 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.907 0.883 . . . . 1.0 112.388 172.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -63.82 -39.33 93.97 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.661 -0.65 . . . . 1.0 112.222 174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -67.05 -39.91 87.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.401 1.08 . . . . 1.0 112.215 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.14 97.14 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.24 -0.912 . . . . 1.0 112.353 173.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.14 -39.49 89.87 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.473 -0.767 . . . . 1.0 112.308 174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.0 -38.24 90.34 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.258 -0.902 . . . . 1.0 112.465 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.6 t -64.9 -40.95 95.89 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.699 -0.626 . . . . 1.0 111.484 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.46 -44.15 97.1 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.51 -0.744 . . . . 1.0 110.939 174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.9 80.26 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.645 0.657 . . . . 1.0 112.348 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -66.45 -43.63 85.07 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.533 0.733 . . . . 1.0 112.561 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -62.4 -40.08 95.35 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 121.527 -0.733 . . . . 1.0 112.357 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -64.35 -40.97 96.93 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.742 0.817 . . . . 1.0 111.5 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -64.07 -25.47 68.12 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.602 0.964 . . . . 1.0 113.602 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -63.51 -30.45 71.57 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 120.951 -1.093 . . . . 1.0 112.328 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.81 -12.42 54.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.28 1.032 . . . . 1.0 112.954 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -62.75 -11.85 20.24 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.768 1.227 . . . . 1.0 113.4 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.31 17.59 55.36 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.718 1.152 . . . . 1.0 113.89 170.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -131.39 158.81 39.78 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 122.734 1.254 . . . . 1.0 113.629 -170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -96.59 150.12 21.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.972 2.109 . . . . 1.0 109.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.52 -172.84 15.38 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.991 1.758 . . . . 1.0 114.014 -173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.43 118.28 8.72 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 127.811 2.444 . . . . 1.0 109.395 -169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.4 t -73.14 128.13 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.437 0.695 . . . . 1.0 110.541 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 0.18 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.256 1.422 . . . . 1.0 113.541 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.1 m -150.75 127.08 10.65 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 105.953 -1.869 . . . . 1.0 105.953 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.07 139.6 40.86 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.67 94.73 48.95 Favored Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 126.428 1.891 . . . . 1.0 108.598 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 172.92 15.41 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.335 2.023 . . . . 1.0 112.913 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.32 -21.86 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 115.343 1.608 . . . . 1.0 115.343 -170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.05 24.07 1.84 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.368 1.867 . . . . 1.0 112.148 -176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.05 -164.79 10.11 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.696 1.141 . . . . 1.0 114.493 -171.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -128.74 145.73 51.09 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.771 1.228 . . . . 1.0 112.552 -169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.78 -141.04 3.29 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.947 2.213 . . . . 1.0 110.334 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -142.63 149.25 38.69 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.625 1.212 . . . . 1.0 112.993 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.03 152.57 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.97 1.708 . . . . 1.0 111.329 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.13 146.6 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.772 2.029 . . . . 1.0 108.649 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 34.1 mm -71.19 153.3 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.53 -0.731 . . . . 1.0 109.726 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.37 -18.33 6.5 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.512 1.671 . . . . 1.0 115.512 -170.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.8 46.18 2.58 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.281 1.42 . . . . 1.0 112.409 169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.11 -26.74 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 127.551 2.341 . . . . 1.0 116.366 -169.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.92 -5.48 77.32 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.328 1.442 . . . . 1.0 115.239 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.83 28.6 2.01 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 126.066 1.793 . . . . 1.0 113.554 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.6 p -136.79 178.91 6.71 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.341 2.256 . . . . 1.0 110.72 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 72.0 mt -128.87 124.94 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.139 1.376 . . . . 1.0 108.514 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 p -68.17 150.8 47.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.012 0.925 . . . . 1.0 112.583 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -139.33 161.27 37.85 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.253 1.821 . . . . 1.0 110.694 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.4 m -63.95 150.16 45.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.011 0.525 . . . . 1.0 111.049 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.56 147.12 35.39 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.15 156.03 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.854 2.062 . . . . 1.0 111.172 172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.5 t -77.21 122.6 25.27 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.967 173.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -76.08 -17.96 59.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.293 1.037 . . . . 1.0 113.199 170.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.12 13.47 12.08 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.794 1.238 . . . . 1.0 113.336 -169.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 49.03 45.88 22.7 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 126.154 1.782 . . . . 1.0 113.473 -174.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -107.31 153.95 21.99 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.772 1.229 . . . . 1.0 111.133 172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.09 120.14 28.05 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.262 -1.014 . . . . 1.0 108.262 170.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -118.89 90.92 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 125.563 1.545 . . . . 1.0 108.784 -171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -62.92 165.35 6.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.314 1.046 . . . . 1.0 113.184 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -50.8 138.78 18.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.588 1.155 . . . . 1.0 112.286 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.96 35.79 34.02 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 115.851 1.1 . . . . 1.0 115.851 169.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -125.29 154.91 41.02 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.233 1.516 . . . . 1.0 112.899 172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 66.8 m -89.48 127.94 35.91 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.133 1.373 . . . . 1.0 110.496 -174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -132.8 145.61 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.416 1.487 . . . . 1.0 112.025 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.5 tp -93.4 127.18 38.91 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -75.39 124.89 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.4 m -121.19 -19.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.497 1.119 . . . . 1.0 113.984 -169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -149.9 160.61 43.46 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.254 1.422 . . . . 1.0 108.488 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -148.85 134.53 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 121.104 -0.998 . . . . 1.0 110.216 -171.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -143.67 90.1 2.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.948 1.299 . . . . 1.0 112.019 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.1 t30 40.69 53.05 3.15 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 126.893 2.077 . . . . 1.0 115.876 169.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.88 55.61 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.933 1.254 . . . . 1.0 114.591 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.78 99.88 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.238 1.815 . . . . 1.0 108.297 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -82.99 145.95 29.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.691 1.196 . . . . 1.0 109.854 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.8 m -108.67 122.7 47.66 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.558 1.143 . . . . 1.0 108.246 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.68 161.7 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.416 0.686 . . . . 1.0 112.15 -169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.0 t -142.2 141.09 20.38 Favored Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 124.388 1.075 . . . . 1.0 109.955 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.71 93.4 0.69 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.98 2.453 . . . . 1.0 112.499 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -60.64 -37.25 80.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.49 1.116 . . . . 1.0 111.142 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 35.8 55.53 2.56 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 127.512 2.325 . . . . 1.0 115.291 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -68.55 157.26 62.55 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.148 2.566 . . . . 1.0 112.361 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 126.006 1.722 . . . . 1.0 110.067 -176.335 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.292 0 N-CA-C 114.748 0.659 . . . . 1.0 114.748 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.5 p -56.09 -35.95 67.6 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.673 1.189 . . . . 1.0 113.304 177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -58.5 -35.37 72.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.78 1.232 . . . . 1.0 113.342 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.6 tpt -76.49 -34.99 58.62 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.407 -0.808 . . . . 1.0 111.833 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.01 -42.2 94.65 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.664 -0.647 . . . . 1.0 111.597 172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.08 -40.6 96.6 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 1.0 112.294 172.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.0 m -63.34 -39.59 94.95 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.628 -0.67 . . . . 1.0 112.218 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.8 m -67.21 -37.05 82.97 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.215 1.006 . . . . 1.0 112.524 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.32 87.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.472 0.709 . . . . 1.0 112.149 173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.81 -40.52 95.35 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.634 0.774 . . . . 1.0 112.19 174.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.51 -38.07 89.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 1.0 112.33 172.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.8 m -66.29 -37.84 86.35 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.6 -0.688 . . . . 1.0 111.883 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.51 -43.43 90.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.469 -0.77 . . . . 1.0 110.613 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.12 -37.06 76.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.684 0.674 . . . . 1.0 112.171 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -66.88 -42.53 85.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.568 0.747 . . . . 1.0 112.698 173.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.82 -38.27 84.85 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.423 -0.798 . . . . 1.0 112.312 171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -67.19 -43.03 83.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.663 0.785 . . . . 1.0 112.029 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -62.1 -27.18 68.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.525 1.057 . . . . 1.0 113.433 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.05 -30.52 70.37 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.006 -1.059 . . . . 1.0 112.938 170.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.3 mt -65.7 -14.75 61.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.769 0.828 . . . . 1.0 113.017 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -64.54 -9.26 17.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.957 1.303 . . . . 1.0 113.593 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.73 19.0 42.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.114 1.34 . . . . 1.0 113.687 170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -131.0 159.2 38.19 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.969 1.307 . . . . 1.0 113.595 -172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 tp -100.16 150.48 22.46 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.76 2.024 . . . . 1.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.82 -173.01 14.96 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.594 1.569 . . . . 1.0 114.642 -172.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.37 117.8 9.69 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 128.257 2.623 . . . . 1.0 109.292 -169.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.79 127.74 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.649 0.779 . . . . 1.0 110.479 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.15 -1.5 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.372 1.469 . . . . 1.0 113.556 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.1 m -149.89 126.7 11.07 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 139.68 43.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.178 0.991 . . . . 1.0 113.479 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.2 t -119.41 97.48 50.21 Favored Pre-proline 0 N--CA 1.47 0.566 0 C-N-CA 126.234 1.814 . . . . 1.0 108.471 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.14 174.56 12.6 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.241 1.96 . . . . 1.0 112.749 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.5 m -55.1 -26.05 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 115.526 1.676 . . . . 1.0 115.526 -169.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -140.83 24.35 2.2 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.246 1.818 . . . . 1.0 112.16 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.17 -164.9 10.6 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.727 1.156 . . . . 1.0 114.362 -171.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.67 145.55 51.12 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.735 1.214 . . . . 1.0 112.306 -169.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.15 -142.48 3.53 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.876 2.179 . . . . 1.0 110.396 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -143.01 148.96 37.63 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.587 1.194 . . . . 1.0 113.115 -174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.2 p -138.35 153.16 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.209 1.804 . . . . 1.0 111.446 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.5 p -133.66 145.84 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.717 2.007 . . . . 1.0 108.786 169.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -71.44 155.31 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.469 -0.77 . . . . 1.0 109.996 175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -53.76 -21.57 7.56 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.918 1.822 . . . . 1.0 115.918 -171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.65 46.08 1.65 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.118 1.342 . . . . 1.0 113.671 169.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -48.65 -26.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 127.187 2.195 . . . . 1.0 115.484 -169.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.31 -5.38 76.05 Favored Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.376 1.465 . . . . 1.0 115.203 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.6 27.62 2.07 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 126.275 1.893 . . . . 1.0 113.575 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.5 p -136.18 178.86 6.73 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.369 2.267 . . . . 1.0 110.697 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 80.7 mt -128.91 124.81 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.25 1.42 . . . . 1.0 108.066 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.0 p -66.79 152.47 45.48 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.001 0.921 . . . . 1.0 112.371 175.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -139.17 159.73 41.46 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.961 1.704 . . . . 1.0 110.549 -175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.9 m -64.2 151.27 43.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.808 0.443 . . . . 1.0 110.764 170.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.76 146.87 34.71 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.184 0.809 . . . . 1.0 113.184 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.24 154.23 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 126.497 1.919 . . . . 1.0 111.338 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -79.46 110.15 14.49 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.623 -0.673 . . . . 1.0 111.432 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -67.91 -32.2 72.51 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.665 0.786 . . . . 1.0 112.623 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -93.84 4.13 54.38 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.725 1.21 . . . . 1.0 113.548 -173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 55.34 47.57 21.07 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.513 1.525 . . . . 1.0 111.942 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -135.82 151.59 50.22 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.327 1.851 . . . . 1.0 111.18 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.08 137.06 37.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.218 0.607 . . . . 1.0 110.47 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -131.31 94.86 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.08 1.352 . . . . 1.0 109.018 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.0 p -71.3 166.45 21.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.606 1.163 . . . . 1.0 113.446 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -53.82 136.37 40.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.557 1.143 . . . . 1.0 112.187 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.77 3.96 76.44 Favored Glycine 0 CA--C 1.534 1.279 0 N-CA-C 116.596 1.398 . . . . 1.0 116.596 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.5 t -95.89 160.16 14.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.161 1.981 . . . . 1.0 112.618 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -94.53 125.89 39.47 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.347 1.459 . . . . 1.0 110.617 -175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 m -131.38 145.76 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 1.0 112.637 -169.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.8 tp -95.93 126.94 41.53 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 169.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.0 t -74.93 122.9 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 169.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.66 -20.54 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 -169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -150.48 160.9 43.44 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.035 1.334 . . . . 1.0 108.67 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.8 mt -148.37 135.09 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.057 -1.027 . . . . 1.0 110.142 -169.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -152.67 112.31 3.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.774 1.23 . . . . 1.0 110.749 -176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 34.6 55.96 0.69 Allowed 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 117.068 2.247 . . . . 1.0 117.068 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 8.11 87.2 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.889 -1.132 . . . . 1.0 115.012 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.81 83.75 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 128.088 2.555 . . . . 1.0 107.383 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.37 148.69 49.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.973 1.309 . . . . 1.0 110.253 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 m -108.89 122.09 46.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.535 1.134 . . . . 1.0 108.243 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.47 162.45 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.398 0.679 . . . . 1.0 112.032 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -143.87 141.15 18.09 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 124.586 1.155 . . . . 1.0 110.17 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.92 94.29 0.63 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.953 2.436 . . . . 1.0 112.135 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -63.7 -35.84 81.88 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.506 1.123 . . . . 1.0 111.565 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 35.21 52.03 1.42 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 127.153 2.181 . . . . 1.0 116.602 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -68.51 158.57 57.1 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.092 2.528 . . . . 1.0 112.738 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.1 mm . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 126.059 1.744 . . . . 1.0 109.972 -177.521 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.36 0 N-CA-C 114.739 0.656 . . . . 1.0 114.739 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.3 p -55.81 -33.92 64.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.817 1.247 . . . . 1.0 114.029 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.11 -28.5 70.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.623 0.971 . . . . 1.0 113.623 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.3 mmt -72.27 -36.42 69.01 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.378 -0.826 . . . . 1.0 111.626 172.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -68.62 -40.06 80.55 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.79 0.836 . . . . 1.0 111.45 174.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.72 -41.35 98.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.853 0.861 . . . . 1.0 112.148 172.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t -61.7 -42.36 98.84 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.37 0.668 . . . . 1.0 111.863 172.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 t -63.08 -41.51 99.44 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.752 0.821 . . . . 1.0 112.353 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.46 -40.58 95.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.667 0.787 . . . . 1.0 112.679 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -65.7 -40.91 92.8 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.288 -0.882 . . . . 1.0 112.396 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.7 -35.66 81.4 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.242 -0.912 . . . . 1.0 112.457 172.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.4 m -65.99 -38.65 89.04 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.607 -0.683 . . . . 1.0 111.793 172.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -65.38 -42.97 92.15 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.474 -0.766 . . . . 1.0 110.825 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -36.71 75.9 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.591 -0.693 . . . . 1.0 112.373 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -66.65 -43.39 84.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.454 0.702 . . . . 1.0 112.569 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -60.73 -39.34 88.29 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.625 0.77 . . . . 1.0 112.515 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.93 -44.05 81.65 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.2 1.0 . . . . 1.0 111.936 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.69 -29.69 70.69 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.414 -0.803 . . . . 1.0 113.136 174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.63 -30.46 69.88 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.129 -0.982 . . . . 1.0 112.831 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.65 -20.54 64.91 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.95 0.722 . . . . 1.0 112.95 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -66.44 -3.43 6.13 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.608 1.563 . . . . 1.0 113.596 171.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -116.36 22.94 10.77 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.23 1.871 . . . . 1.0 113.256 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -131.27 157.43 43.3 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.21 1.404 . . . . 1.0 113.106 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.8 156.57 21.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.938 -1.028 . . . . 1.0 110.416 169.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.53 -172.25 13.69 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.761 2.124 . . . . 1.0 112.911 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.13 117.43 9.6 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.921 2.488 . . . . 1.0 109.303 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.38 126.2 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.312 0.645 . . . . 1.0 110.564 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.75 -10.3 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.044 1.337 . . . . 1.0 113.55 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -141.54 126.6 18.37 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.794 1.638 . . . . 1.0 106.689 169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.76 142.36 34.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.362 1.065 . . . . 1.0 113.566 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.3 t -120.93 93.94 48.87 Favored Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 125.863 1.665 . . . . 1.0 107.97 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.32 170.88 18.13 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.334 2.023 . . . . 1.0 112.503 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -56.81 -21.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 115.617 1.71 . . . . 1.0 115.617 -169.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.03 30.99 1.14 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.674 1.59 . . . . 1.0 111.256 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.19 -162.65 9.21 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.63 1.11 . . . . 1.0 114.38 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -128.78 145.84 51.08 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.877 1.271 . . . . 1.0 112.798 -169.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.02 -142.14 3.56 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.72 2.105 . . . . 1.0 110.416 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -142.92 149.4 38.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.355 1.077 . . . . 1.0 112.869 -176.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -137.82 151.78 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.524 1.93 . . . . 1.0 110.801 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 p -129.61 145.3 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.013 1.725 . . . . 1.0 109.02 170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mm -71.44 148.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.473 -0.767 . . . . 1.0 109.602 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -49.76 -19.3 0.62 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 117.821 2.526 . . . . 1.0 117.821 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.47 40.25 1.76 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.757 1.17 . . . . 1.0 113.206 169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.11 -26.8 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 129.183 2.993 . . . . 1.0 116.426 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.82 -11.67 85.22 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.828 1.204 . . . . 1.0 115.208 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.48 0.28 Allowed Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.097 1.332 . . . . 1.0 115.389 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.1 p -71.81 179.37 3.18 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.911 1.356 . . . . 1.0 111.93 169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.59 133.36 66.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.422 1.489 . . . . 1.0 109.346 -172.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.3 p -70.76 149.77 46.56 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.308 1.043 . . . . 1.0 112.953 176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -141.96 158.61 43.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.986 2.114 . . . . 1.0 109.984 -174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.9 m -66.08 150.82 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.986 0.515 . . . . 1.0 111.101 169.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.74 147.66 34.52 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.852 1.056 . . . . 1.0 113.852 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.23 155.56 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 127.016 2.126 . . . . 1.0 110.912 170.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.6 t -79.49 123.74 27.83 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.438 -0.789 . . . . 1.0 111.09 173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -77.85 -11.69 59.91 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.413 1.085 . . . . 1.0 113.045 170.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -125.79 17.03 8.04 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.445 1.498 . . . . 1.0 112.579 -169.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.4 m120 47.04 45.16 15.63 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.676 1.99 . . . . 1.0 113.917 -175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -101.07 155.93 17.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.109 1.364 . . . . 1.0 111.42 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -96.58 85.08 3.78 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.35 1.06 . . . . 1.0 109.108 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 mt -84.64 94.65 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.938 1.295 . . . . 1.0 109.511 -169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -65.02 165.43 11.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.216 1.007 . . . . 1.0 113.147 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -50.58 142.42 10.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.904 1.282 . . . . 1.0 112.941 170.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.18 32.55 47.99 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 116.463 1.345 . . . . 1.0 116.463 169.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 t -124.64 154.79 40.2 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.294 1.547 . . . . 1.0 112.594 173.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.7 m -91.96 126.75 37.16 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.304 1.041 . . . . 1.0 110.12 -174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 m -128.62 145.16 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.59 1.556 . . . . 1.0 110.662 -169.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.5 tp -91.79 126.79 37.0 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.887 -0.782 . . . . 1.0 108.887 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.46 118.32 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.48 -20.43 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.623 1.169 . . . . 1.0 113.362 -171.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -149.82 163.93 36.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.741 1.216 . . . . 1.0 109.544 169.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.9 mt -146.27 133.15 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.239 1.016 . . . . 1.0 109.473 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -135.37 83.08 1.99 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.761 1.625 . . . . 1.0 110.944 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.9 t30 49.5 35.66 8.7 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.218 1.807 . . . . 1.0 115.665 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.58 -13.85 22.73 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.079 1.323 . . . . 1.0 114.263 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 t -99.94 103.14 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.285 1.434 . . . . 1.0 108.332 170.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.07 146.8 33.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.242 1.017 . . . . 1.0 109.886 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 m -108.85 122.16 46.61 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 171.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.33 162.68 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.279 0.561 . . . . 1.0 112.183 -169.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.1 t -144.49 141.18 17.5 Favored Pre-proline 0 N--CA 1.474 0.731 0 C-N-CA 124.519 1.128 . . . . 1.0 110.093 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.57 91.88 0.59 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.252 2.635 . . . . 1.0 112.514 -177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.26 -35.14 79.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.27 1.028 . . . . 1.0 111.184 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 39.0 53.93 4.61 Favored Pre-proline 0 CA--C 1.559 1.307 0 C-N-CA 126.765 2.026 . . . . 1.0 115.025 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -68.16 157.91 59.74 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 123.15 2.567 . . . . 1.0 112.595 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 125.749 1.619 . . . . 1.0 109.785 -178.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.307 0 N-CA-C 114.798 0.679 . . . . 1.0 114.798 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 m -54.68 -35.75 63.9 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.948 1.299 . . . . 1.0 114.015 -175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.01 -38.77 92.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.59 -0.694 . . . . 1.0 112.683 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -68.41 -42.58 78.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.576 0.75 . . . . 1.0 111.227 173.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.6 mt -63.98 -37.37 87.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.512 0.725 . . . . 1.0 112.847 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -69.62 -37.08 76.68 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 120.994 -1.066 . . . . 1.0 112.333 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 t -63.46 -44.81 93.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.692 -0.63 . . . . 1.0 112.125 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.5 p -67.56 -36.52 81.1 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.302 -0.874 . . . . 1.0 113.009 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.31 96.17 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.439 -0.788 . . . . 1.0 112.289 172.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -66.99 -37.71 84.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.383 -0.823 . . . . 1.0 112.22 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -63.52 -38.38 90.9 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.128 -0.983 . . . . 1.0 112.342 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.8 m -65.75 -37.28 85.93 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.495 -0.753 . . . . 1.0 111.87 172.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.02 -39.06 83.2 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.399 -0.813 . . . . 1.0 111.278 173.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.88 -36.81 82.37 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.196 -0.94 . . . . 1.0 112.396 172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -64.79 -41.13 96.07 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.249 -0.907 . . . . 1.0 112.81 171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -63.8 -40.93 97.81 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.466 -0.772 . . . . 1.0 112.483 171.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.65 -37.22 85.5 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.681 1.192 . . . . 1.0 111.827 175.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.02 -22.18 66.82 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.685 0.994 . . . . 1.0 113.685 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -65.02 -30.53 71.51 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.929 -1.107 . . . . 1.0 112.392 169.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.9 mt -66.06 -13.99 60.93 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.714 1.206 . . . . 1.0 113.048 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -55.29 -26.6 41.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.875 1.27 . . . . 1.0 113.177 174.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.93 13.27 54.76 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.378 0.99 . . . . 1.0 115.188 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -131.21 159.3 38.16 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.106 1.453 . . . . 1.0 113.2 -173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.62 158.0 25.82 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.311 1.045 . . . . 1.0 110.325 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.69 -174.06 13.27 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.83 2.157 . . . . 1.0 112.764 173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.75 115.86 7.92 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.173 2.189 . . . . 1.0 109.642 -169.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.6 t -73.53 134.28 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.15 0.98 . . . . 1.0 111.152 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -12.21 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.935 1.694 . . . . 1.0 113.231 -173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.7 128.3 20.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.347 1.859 . . . . 1.0 106.054 169.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.3 137.8 46.77 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.494 0.924 . . . . 1.0 113.494 -169.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.42 96.69 49.74 Favored Pre-proline 0 N--CA 1.47 0.557 0 C-N-CA 126.541 1.936 . . . . 1.0 108.186 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.74 174.6 12.35 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.44 2.093 . . . . 1.0 112.852 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -55.03 -27.67 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.985 1.714 . . . . 1.0 115.463 -169.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -142.85 31.46 1.43 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.448 1.499 . . . . 1.0 111.03 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.39 -164.56 9.93 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.616 1.103 . . . . 1.0 114.235 -173.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.71 145.67 51.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.837 1.255 . . . . 1.0 112.11 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.74 3.82 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.859 2.171 . . . . 1.0 109.818 171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.87 154.48 43.41 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.364 1.082 . . . . 1.0 112.795 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.41 158.28 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.466 1.906 . . . . 1.0 111.339 -175.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -128.8 145.51 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.634 1.974 . . . . 1.0 108.425 169.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.28 148.55 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 119.933 1.242 . . . . 1.0 109.613 170.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.64 -12.29 6.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.5 2.037 . . . . 1.0 116.5 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.42 40.66 0.92 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.508 1.528 . . . . 1.0 114.067 169.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.35 -22.2 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 127.585 2.354 . . . . 1.0 116.951 -169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.25 -16.77 62.95 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.419 1.009 . . . . 1.0 115.085 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.95 -9.98 0.09 OUTLIER Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.086 1.594 . . . . 1.0 117.086 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.14 172.36 9.34 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 119.802 1.801 . . . . 1.0 113.123 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.7 mt -129.42 138.8 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.693 1.597 . . . . 1.0 109.689 -172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 p -71.35 149.58 45.91 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.606 1.162 . . . . 1.0 113.449 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -143.14 162.78 34.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.564 1.946 . . . . 1.0 111.152 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.4 t -67.37 150.97 48.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.966 0.506 . . . . 1.0 110.663 169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.78 146.92 36.52 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.483 0.92 . . . . 1.0 113.483 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.07 154.2 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 126.42 1.888 . . . . 1.0 111.818 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -81.3 108.91 15.33 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.638 -0.664 . . . . 1.0 111.339 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -67.29 -33.82 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.485 0.714 . . . . 1.0 112.546 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.5 5.46 50.73 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.813 1.245 . . . . 1.0 113.497 -172.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 54.16 48.55 20.69 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.281 1.432 . . . . 1.0 112.139 -175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -135.54 154.77 51.27 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.191 1.796 . . . . 1.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.16 135.23 34.05 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.237 0.615 . . . . 1.0 110.186 -174.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -130.21 100.76 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.773 1.229 . . . . 1.0 109.344 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 p -73.98 168.75 18.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.898 1.279 . . . . 1.0 113.42 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -52.55 140.58 22.52 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.794 1.238 . . . . 1.0 112.562 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 33.13 49.34 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 115.782 1.073 . . . . 1.0 115.782 169.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -124.09 153.75 40.98 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.142 1.471 . . . . 1.0 112.269 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.6 m -92.44 128.57 38.34 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.252 1.021 . . . . 1.0 110.056 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.29 145.36 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.501 1.52 . . . . 1.0 110.915 -169.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 65.8 tp -92.56 128.89 38.58 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.448 -0.783 . . . . 1.0 109.034 169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.4 t -81.06 77.01 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.209 1.004 . . . . 1.0 110.389 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 69' ' ' VAL . 2.9 m -70.02 -23.78 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 115.25 1.574 . . . . 1.0 115.25 -170.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -147.1 164.35 33.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.036 0.935 . . . . 1.0 109.835 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.7 mt -145.42 138.61 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.19 -0.943 . . . . 1.0 110.62 -174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -134.65 161.22 35.72 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.056 2.142 . . . . 1.0 108.419 169.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -47.52 95.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.304 1.842 . . . . 1.0 114.317 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.75 10.54 64.39 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 125.663 1.602 . . . . 1.0 115.919 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 t -134.44 88.76 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.909 2.084 . . . . 1.0 108.633 -176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.55 147.29 35.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.135 1.374 . . . . 1.0 110.389 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 m -108.97 120.4 42.43 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.261 1.025 . . . . 1.0 108.255 174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -130.34 163.82 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 112.793 0.664 . . . . 1.0 112.793 -169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.19 140.98 15.04 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 125.031 1.333 . . . . 1.0 109.625 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.44 91.29 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.064 2.509 . . . . 1.0 112.722 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -66.32 -36.0 81.81 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.358 1.063 . . . . 1.0 111.088 172.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 38.95 54.27 4.75 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 126.869 2.067 . . . . 1.0 114.776 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -69.72 159.33 53.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.417 2.745 . . . . 1.0 112.745 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.603 1.561 . . . . 1.0 110.435 -178.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.336 0 N-CA-C 114.503 0.561 . . . . 1.0 114.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.6 p -57.17 -37.27 71.85 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.413 1.107 . . . . 1.0 112.84 174.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -59.2 -31.67 69.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.992 1.317 . . . . 1.0 113.689 172.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -73.86 -40.32 63.34 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.273 -0.892 . . . . 1.0 111.454 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.1 mt -63.58 -41.09 98.4 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.408 0.683 . . . . 1.0 111.594 174.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.23 -39.27 93.61 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.878 0.871 . . . . 1.0 112.435 172.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -62.35 -40.32 96.03 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.622 -0.674 . . . . 1.0 112.101 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 m -66.84 -36.68 82.9 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.667 0.787 . . . . 1.0 112.871 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.42 -44.0 88.75 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.895 0.771 . . . . 1.0 112.281 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.75 -37.0 83.76 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.333 -0.854 . . . . 1.0 112.544 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -63.88 -38.76 92.28 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.315 -0.865 . . . . 1.0 112.186 171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 56.1 m -66.25 -35.98 81.82 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.407 -0.808 . . . . 1.0 112.204 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 tt -66.73 -43.68 83.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.735 0.814 . . . . 1.0 110.6 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.6 73.8 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.314 -0.866 . . . . 1.0 112.134 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -67.28 -36.76 82.22 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.647 0.779 . . . . 1.0 112.915 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -64.74 -39.9 94.42 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.437 1.017 . . . . 1.0 112.482 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.64 -45.42 94.12 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.448 0.567 . . . . 1.0 111.529 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.03 -20.83 59.91 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.11 -38.23 90.35 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.24 -0.912 . . . . 1.0 112.373 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mp -68.08 -24.38 65.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.395 1.078 . . . . 1.0 112.191 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -67.21 -6.41 17.93 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.079 1.352 . . . . 1.0 113.643 174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.0 17.22 45.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.554 1.549 . . . . 1.0 113.818 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -131.11 152.35 50.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.366 1.466 . . . . 1.0 112.201 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.31 158.53 24.72 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.124 0.964 . . . . 1.0 108.772 168.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -139.3 -175.99 14.47 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.801 2.143 . . . . 1.0 112.595 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -144.46 115.04 7.67 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.037 2.135 . . . . 1.0 109.531 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.4 t -73.17 134.41 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.008 0.923 . . . . 1.0 111.13 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.66 -12.92 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 125.864 1.666 . . . . 1.0 113.35 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -141.07 128.38 21.05 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.065 -1.828 . . . . 1.0 106.065 169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.05 137.4 46.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.502 0.927 . . . . 1.0 113.502 -169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.37 92.92 41.64 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 126.491 1.917 . . . . 1.0 108.123 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.0 172.18 16.87 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.235 1.956 . . . . 1.0 112.845 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -53.66 -27.36 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 115.77 1.767 . . . . 1.0 115.77 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -142.42 31.67 1.51 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.62 1.568 . . . . 1.0 111.186 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.23 -164.98 10.09 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.777 1.179 . . . . 1.0 114.115 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.68 145.7 51.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.82 1.248 . . . . 1.0 112.293 -169.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.79 -143.62 3.79 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.91 2.195 . . . . 1.0 110.017 171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -144.07 155.03 43.81 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.236 1.018 . . . . 1.0 112.753 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.11 158.68 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.661 1.984 . . . . 1.0 111.377 -175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.21 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 126.281 1.832 . . . . 1.0 108.188 169.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -71.62 147.93 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.633 1.106 . . . . 1.0 109.763 171.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -59.77 -12.83 8.04 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.681 2.104 . . . . 1.0 116.681 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.78 40.96 1.0 Allowed Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.329 1.442 . . . . 1.0 113.887 169.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.252 1.8 pp -47.84 -22.5 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 127.823 2.449 . . . . 1.0 116.987 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.16 -16.48 64.59 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 124.419 1.009 . . . . 1.0 114.998 170.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.5 -10.57 0.1 OUTLIER Glycine 0 CA--C 1.541 1.684 0 N-CA-C 116.939 1.536 . . . . 1.0 116.939 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 40.0 p -71.15 173.24 7.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 119.77 1.785 . . . . 1.0 113.074 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 87.3 mt -129.53 140.19 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.793 1.637 . . . . 1.0 109.617 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.8 p -70.37 150.03 46.71 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.5 1.12 . . . . 1.0 113.341 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -143.41 161.5 38.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.523 1.929 . . . . 1.0 111.101 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -69.17 151.15 46.71 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.346 0.658 . . . . 1.0 110.501 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 147.5 34.88 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.067 1.136 . . . . 1.0 114.067 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.22 156.8 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.218 2.207 . . . . 1.0 111.403 172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.7 t -76.74 122.21 24.41 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.428 -0.795 . . . . 1.0 111.163 173.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -78.25 -20.73 51.08 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.826 0.85 . . . . 1.0 113.191 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -117.62 13.91 14.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.877 1.271 . . . . 1.0 113.253 -169.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.33 47.64 22.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.915 1.686 . . . . 1.0 112.342 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -116.77 153.09 33.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.794 1.637 . . . . 1.0 111.017 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.78 123.76 32.28 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.264 -1.013 . . . . 1.0 108.264 172.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -121.59 94.11 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.189 1.396 . . . . 1.0 109.269 -172.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -67.68 167.72 12.64 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.434 1.094 . . . . 1.0 113.395 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -50.63 142.75 10.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.05 1.34 . . . . 1.0 112.601 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.48 35.54 41.42 Favored Glycine 0 CA--C 1.533 1.159 0 N-CA-C 115.983 1.153 . . . . 1.0 115.983 169.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -128.75 154.5 46.31 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.037 1.418 . . . . 1.0 112.362 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.4 m -94.15 126.32 39.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.126 0.97 . . . . 1.0 110.332 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.31 145.37 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.569 1.548 . . . . 1.0 110.794 -169.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.7 tp -93.06 127.67 38.67 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 169.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.35 119.68 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.95 -19.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.543 1.137 . . . . 1.0 113.625 -170.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -152.85 163.5 39.64 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.335 1.454 . . . . 1.0 108.614 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -147.95 137.71 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 O-C-N 120.74 -1.225 . . . . 1.0 110.459 -174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -137.22 80.33 1.8 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.12 1.768 . . . . 1.0 110.691 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.6 t30 44.51 55.09 5.98 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.283 1.833 . . . . 1.0 114.841 173.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.63 -8.32 68.6 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.554 1.073 . . . . 1.0 114.946 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.16 102.27 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.601 1.56 . . . . 1.0 107.987 169.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.2 147.79 31.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.886 0.874 . . . . 1.0 109.803 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 44.9 m -108.35 119.96 41.02 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.688 -1.227 . . . . 1.0 107.688 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.8 162.9 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.363 0.665 . . . . 1.0 112.203 -169.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -144.85 140.96 16.84 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 124.587 1.155 . . . . 1.0 110.266 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.29 91.71 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.21 2.607 . . . . 1.0 112.684 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -37.66 78.99 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.276 1.031 . . . . 1.0 111.605 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 38.12 56.05 4.6 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 126.278 1.831 . . . . 1.0 115.083 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -68.15 159.81 51.53 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.232 2.622 . . . . 1.0 112.684 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.2 mm . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 124.575 1.15 . . . . 1.0 111.366 177.627 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.282 0 N-CA-C 114.641 0.616 . . . . 1.0 114.641 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 m -56.36 -29.82 61.87 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.936 1.294 . . . . 1.0 113.894 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -59.11 -31.27 68.77 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.28 1.032 . . . . 1.0 113.637 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.0 mmt -71.91 -38.86 69.85 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.251 -0.906 . . . . 1.0 111.814 173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 81.0 mt -68.85 -36.09 77.73 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.231 1.012 . . . . 1.0 111.715 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -68.68 -37.82 79.87 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.406 -0.808 . . . . 1.0 112.164 171.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -64.96 -42.92 94.19 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.647 -0.658 . . . . 1.0 112.196 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.3 p -67.5 -36.83 81.85 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.419 -0.8 . . . . 1.0 112.662 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.02 98.83 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.675 0.671 . . . . 1.0 112.374 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -65.29 -41.89 93.67 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.374 -0.829 . . . . 1.0 112.115 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.61 -33.42 75.63 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.115 -0.99 . . . . 1.0 112.857 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -64.74 -42.19 95.38 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.617 -0.677 . . . . 1.0 111.52 171.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.44 -42.46 98.66 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.304 -0.872 . . . . 1.0 111.191 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.68 78.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.953 0.797 . . . . 1.0 112.29 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.93 -42.05 90.59 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.525 0.73 . . . . 1.0 112.704 172.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -64.0 -39.45 94.14 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 121.456 -0.777 . . . . 1.0 112.448 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -64.52 -39.46 93.82 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.39 1.076 . . . . 1.0 111.672 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.18 -23.92 67.65 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 119.36 0.982 . . . . 1.0 113.423 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.27 -30.59 71.7 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.028 -1.045 . . . . 1.0 112.463 169.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.9 mt -67.63 -13.1 61.79 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.623 1.169 . . . . 1.0 113.282 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -55.86 -27.06 49.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.648 1.179 . . . . 1.0 113.21 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.84 13.34 53.97 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.467 1.032 . . . . 1.0 115.103 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -130.58 159.24 37.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.004 1.402 . . . . 1.0 113.119 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.88 157.67 25.57 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.646 1.178 . . . . 1.0 110.445 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.37 -174.35 13.38 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.557 2.027 . . . . 1.0 112.739 172.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -145.51 116.53 7.83 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 127.251 2.221 . . . . 1.0 109.016 -169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 91.9 t -73.22 132.0 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.203 1.001 . . . . 1.0 110.752 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.63 -14.81 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.039 1.336 . . . . 1.0 113.743 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 88.4 m -134.92 127.65 31.03 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 106.909 -1.515 . . . . 1.0 106.909 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.98 138.96 42.43 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.3 t -118.31 94.72 47.51 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.57 1.948 . . . . 1.0 108.302 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.7 172.78 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.481 2.121 . . . . 1.0 112.988 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.58 -22.0 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 115.683 1.734 . . . . 1.0 115.683 -169.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -145.46 30.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.508 1.523 . . . . 1.0 111.2 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.35 -164.59 9.96 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.618 1.104 . . . . 1.0 114.209 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.72 145.63 51.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.834 1.254 . . . . 1.0 112.61 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.2 -148.07 4.67 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.928 2.204 . . . . 1.0 110.246 171.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -141.1 148.92 40.9 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.668 1.234 . . . . 1.0 112.397 -176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.55 156.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 127.175 2.19 . . . . 1.0 110.544 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.19 147.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.843 2.057 . . . . 1.0 107.982 169.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.1 mm -67.49 150.28 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -58.3 -9.93 1.78 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 117.108 2.262 . . . . 1.0 117.108 -169.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.98 42.21 1.33 Allowed Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.917 1.246 . . . . 1.0 113.067 169.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.17 -26.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.743 2.417 . . . . 1.0 116.407 -169.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.82 -15.29 62.1 Favored Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.506 1.051 . . . . 1.0 115.311 172.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.95 -9.86 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 N-CA-C 116.791 1.477 . . . . 1.0 116.791 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.3 p -69.42 173.13 6.18 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 119.697 1.749 . . . . 1.0 112.907 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.1 mm -128.36 127.78 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.52 1.528 . . . . 1.0 108.648 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 m -66.93 145.14 55.76 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.615 0.766 . . . . 1.0 111.617 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -137.8 156.37 48.02 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.835 1.654 . . . . 1.0 110.123 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -63.96 148.92 48.42 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.738 0.415 . . . . 1.0 111.054 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.21 145.86 36.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.791 0.836 . . . . 1.0 112.766 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.04 155.77 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.459 1.903 . . . . 1.0 110.937 172.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 t -78.37 124.2 27.84 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.38 -0.825 . . . . 1.0 111.09 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -78.75 -14.12 59.45 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.308 1.043 . . . . 1.0 113.163 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -123.9 16.46 9.35 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.18 1.392 . . . . 1.0 112.817 -169.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.3 46.44 16.86 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.574 1.95 . . . . 1.0 113.772 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.57 152.78 22.65 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.255 1.422 . . . . 1.0 111.018 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.99 120.87 31.57 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.968 -1.123 . . . . 1.0 107.968 169.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.32 90.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.344 1.458 . . . . 1.0 109.171 -170.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.9 m -65.56 168.44 7.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.445 1.098 . . . . 1.0 113.237 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -50.02 141.42 10.85 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.813 1.245 . . . . 1.0 112.21 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.89 35.68 30.62 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 116.433 1.333 . . . . 1.0 116.433 169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -129.99 154.62 47.2 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 119.408 1.604 . . . . 1.0 112.688 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 61.7 m -91.83 129.17 37.85 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.518 1.127 . . . . 1.0 110.313 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.13 145.29 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.639 1.576 . . . . 1.0 110.782 -169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 tp -92.89 128.39 38.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.46 -0.775 . . . . 1.0 109.22 170.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.5 t -82.56 76.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.605 1.162 . . . . 1.0 110.44 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 69' ' ' VAL . 6.0 m -69.82 -22.2 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 115.468 1.655 . . . . 1.0 115.468 -170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.74 161.92 39.6 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.525 1.057 . . . . 1.0 110.799 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.7 mt -147.0 132.7 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.675 1.19 . . . . 1.0 110.123 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -144.98 90.2 2.03 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.669 1.188 . . . . 1.0 112.028 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.0 t30 40.59 54.25 3.02 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.629 1.972 . . . . 1.0 115.707 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.14 -6.13 59.61 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.947 1.26 . . . . 1.0 114.577 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.6 97.42 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.308 1.843 . . . . 1.0 108.282 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.61 147.02 30.9 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.997 1.319 . . . . 1.0 109.93 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m -111.43 122.94 49.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.433 1.093 . . . . 1.0 108.291 171.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.33 163.66 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.386 0.612 . . . . 1.0 112.293 -169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -147.79 141.29 15.48 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.812 1.245 . . . . 1.0 109.474 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.68 91.27 0.7 Allowed 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.011 2.474 . . . . 1.0 112.762 -175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -64.6 -35.25 80.4 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.368 1.067 . . . . 1.0 111.136 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 38.99 53.63 4.45 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 126.886 2.074 . . . . 1.0 115.17 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -67.51 157.27 62.55 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.129 2.553 . . . . 1.0 112.356 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mm . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 125.986 1.714 . . . . 1.0 109.971 -176.604 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 N-CA-C 114.658 0.623 . . . . 1.0 114.658 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.7 p -56.96 -31.75 65.34 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.719 1.208 . . . . 1.0 113.675 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -60.48 -32.93 71.89 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.669 1.188 . . . . 1.0 113.401 172.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.24 -35.56 68.84 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.321 -0.862 . . . . 1.0 111.937 173.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.4 mt -68.58 -41.78 79.17 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.577 0.751 . . . . 1.0 111.457 175.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.23 -39.86 93.31 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.575 0.75 . . . . 1.0 112.295 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.6 t -61.52 -42.59 99.03 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.674 -0.641 . . . . 1.0 111.847 172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.4 m -64.18 -39.47 94.07 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.381 -0.824 . . . . 1.0 112.441 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.57 -40.5 92.84 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.655 0.782 . . . . 1.0 112.523 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.83 -42.12 90.94 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.42 -0.8 . . . . 1.0 112.195 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -65.69 -34.52 78.39 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.164 -0.96 . . . . 1.0 112.622 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.0 m -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.538 -0.726 . . . . 1.0 111.771 171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.28 -37.17 77.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.225 -0.922 . . . . 1.0 112.335 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.06 73.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.326 -0.859 . . . . 1.0 112.061 169.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -72.93 -40.1 65.73 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.335 0.654 . . . . 1.0 112.097 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -60.02 -38.96 84.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.964 0.905 . . . . 1.0 112.22 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -67.28 -43.03 82.8 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.026 0.531 . . . . 1.0 112.085 172.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.44 -25.67 68.09 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.501 1.046 . . . . 1.0 113.177 176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.79 -30.53 70.87 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.941 -1.1 . . . . 1.0 112.842 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.49 -14.73 62.66 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.044 0.938 . . . . 1.0 112.992 176.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -65.78 -5.41 8.72 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.002 1.721 . . . . 1.0 113.674 173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.65 20.79 24.43 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.651 1.596 . . . . 1.0 113.373 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -130.74 158.82 39.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 113.657 -172.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.23 149.08 21.71 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.784 2.033 . . . . 1.0 109.787 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.3 -173.06 15.37 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.172 1.844 . . . . 1.0 113.98 -173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -145.32 118.21 8.75 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 127.704 2.401 . . . . 1.0 109.352 -169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.2 t -72.86 128.51 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.393 0.677 . . . . 1.0 110.618 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.51 -0.39 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 125.241 1.416 . . . . 1.0 113.659 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.7 m -150.27 127.13 11.05 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.071 -1.826 . . . . 1.0 106.071 168.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.08 139.52 41.2 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.844 1.054 . . . . 1.0 113.844 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.8 t -120.64 94.88 49.0 Favored Pre-proline 0 N--CA 1.472 0.636 0 C-N-CA 126.314 1.845 . . . . 1.0 108.586 -174.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 172.85 15.55 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.226 1.95 . . . . 1.0 112.883 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.4 m -56.1 -21.55 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 115.43 1.641 . . . . 1.0 115.43 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -143.13 24.06 1.82 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.437 1.895 . . . . 1.0 112.146 -176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.67 -165.34 10.47 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.681 1.134 . . . . 1.0 114.346 -171.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -128.72 145.71 51.09 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.745 1.218 . . . . 1.0 112.462 -169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.18 -140.57 3.19 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.919 2.2 . . . . 1.0 110.356 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -143.25 149.3 37.71 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.589 1.194 . . . . 1.0 113.092 -175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.81 152.3 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.117 1.767 . . . . 1.0 111.231 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.23 145.31 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.359 1.864 . . . . 1.0 108.944 169.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -71.63 147.85 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 121.469 -0.769 . . . . 1.0 109.717 176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -50.62 -17.88 0.6 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 117.78 2.511 . . . . 1.0 117.78 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.86 40.2 1.84 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.794 1.187 . . . . 1.0 113.006 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 pp -43.04 -26.83 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 129.287 3.035 . . . . 1.0 116.45 -169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.14 -11.56 85.44 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.87 1.224 . . . . 1.0 115.209 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.26 -18.4 0.29 Allowed Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.18 1.372 . . . . 1.0 115.461 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.6 p -71.14 177.69 3.67 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.927 1.363 . . . . 1.0 111.931 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 70.2 mt -128.76 130.11 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.092 1.357 . . . . 1.0 108.996 -173.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.1 p -71.02 151.72 44.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.264 1.026 . . . . 1.0 113.089 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -142.64 161.53 37.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.707 2.003 . . . . 1.0 110.569 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.3 m -64.27 151.31 44.02 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.124 0.57 . . . . 1.0 111.118 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.95 147.98 34.7 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.907 1.077 . . . . 1.0 113.907 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.34 157.08 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.216 2.206 . . . . 1.0 111.173 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.7 t -78.5 125.88 29.97 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -0.887 . . . . 1.0 111.15 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.91 -14.48 58.6 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.45 1.1 . . . . 1.0 113.185 170.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.42 16.18 9.69 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.109 1.363 . . . . 1.0 112.75 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.5 m120 47.04 46.17 15.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.538 1.935 . . . . 1.0 113.664 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -105.21 153.3 21.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.222 1.409 . . . . 1.0 111.026 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.31 117.46 28.27 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.905 -1.146 . . . . 1.0 107.905 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mt -117.41 90.99 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.455 1.502 . . . . 1.0 108.875 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.7 m -63.72 165.32 8.52 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.434 1.094 . . . . 1.0 113.31 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -50.94 139.8 16.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.796 1.238 . . . . 1.0 112.481 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.76 33.44 42.2 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.799 1.079 . . . . 1.0 115.799 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 t -123.93 154.04 40.31 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.133 1.467 . . . . 1.0 112.679 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.9 m -91.7 125.6 36.48 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.656 1.182 . . . . 1.0 110.502 -172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.68 145.68 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.393 1.477 . . . . 1.0 112.095 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 tp -93.47 127.68 39.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 t -76.77 122.61 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.65 -21.0 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.766 1.226 . . . . 1.0 113.401 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -149.83 162.6 39.97 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.989 1.316 . . . . 1.0 109.0 168.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.0 mt -148.17 137.28 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.214 1.006 . . . . 1.0 110.096 -172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -143.91 92.14 2.3 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.972 1.309 . . . . 1.0 111.873 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.2 t30 41.06 53.68 3.36 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.602 1.961 . . . . 1.0 115.689 169.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.93 -6.27 60.06 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.831 1.205 . . . . 1.0 114.784 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.51 103.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.973 1.709 . . . . 1.0 108.382 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.74 145.5 27.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.796 1.238 . . . . 1.0 109.963 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -108.63 120.52 42.69 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.709 1.203 . . . . 1.0 108.112 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.14 162.61 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 112.739 0.644 . . . . 1.0 112.739 -169.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -143.4 140.81 18.03 Favored Pre-proline 0 N--CA 1.474 0.742 0 C-N-CA 124.507 1.123 . . . . 1.0 110.204 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.7 91.16 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.396 2.73 . . . . 1.0 112.785 -175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.63 -38.68 90.07 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.748 1.219 . . . . 1.0 111.815 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 35.36 56.5 2.45 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.711 2.004 . . . . 1.0 115.394 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.83 158.37 58.13 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.07 2.513 . . . . 1.0 112.677 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.478 0.93 0 C-N-CA 125.779 1.632 . . . . 1.0 109.761 -179.311 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.335 0 N-CA-C 114.869 0.707 . . . . 1.0 114.869 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -54.61 -30.0 53.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.543 1.537 . . . . 1.0 114.71 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -58.43 -34.39 70.75 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.05 0.759 . . . . 1.0 113.05 175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mtm -70.35 -37.45 74.65 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.27 -0.893 . . . . 1.0 111.96 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.61 -41.35 79.68 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.97 0.908 . . . . 1.0 111.238 175.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.78 -40.58 97.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.316 1.047 . . . . 1.0 112.183 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.9 m -63.96 -39.9 95.18 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.287 0.635 . . . . 1.0 112.037 173.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.8 t -64.52 -42.29 95.88 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.934 0.894 . . . . 1.0 111.983 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.99 95.19 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.652 0.781 . . . . 1.0 112.672 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.03 -42.6 89.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.405 -0.809 . . . . 1.0 112.299 176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -64.37 -37.84 88.92 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.449 -0.782 . . . . 1.0 112.177 172.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.1 m -62.39 -39.95 94.9 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.721 -0.612 . . . . 1.0 111.765 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.1 -39.06 86.67 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.567 0.747 . . . . 1.0 111.331 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.2 -37.05 81.6 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.385 -0.822 . . . . 1.0 112.332 172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -68.62 -39.14 80.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.232 -0.918 . . . . 1.0 112.65 173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -61.92 -40.09 94.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.888 0.875 . . . . 1.0 112.134 171.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -67.0 -41.57 86.5 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.758 0.823 . . . . 1.0 112.122 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.18 -25.48 68.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.465 1.03 . . . . 1.0 113.355 175.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.75 -30.47 70.8 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.869 -1.144 . . . . 1.0 112.603 169.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 mt -64.39 -13.69 52.29 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.022 0.929 . . . . 1.0 112.923 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -60.97 -20.73 62.73 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.171 0.989 . . . . 1.0 112.913 171.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.55 15.01 61.25 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.391 0.996 . . . . 1.0 114.255 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -131.39 161.39 32.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.755 1.277 . . . . 1.0 113.551 -169.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.3 149.98 23.46 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.397 2.279 . . . . 1.0 109.232 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.8 -174.16 13.88 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.893 1.711 . . . . 1.0 114.924 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.22 117.04 8.75 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.838 2.455 . . . . 1.0 109.529 -169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.62 134.48 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.989 0.915 . . . . 1.0 111.29 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.35 -11.17 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 126.075 1.75 . . . . 1.0 113.36 -173.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.6 m -143.37 127.12 17.12 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 105.812 -1.921 . . . . 1.0 105.812 169.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.95 140.21 43.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.001 0.92 . . . . 1.0 113.43 -169.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.77 94.86 48.9 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.954 1.702 . . . . 1.0 108.466 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.89 173.37 14.59 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.062 1.841 . . . . 1.0 112.808 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.1 m -56.13 -20.26 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 115.348 1.61 . . . . 1.0 115.348 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -143.23 24.02 1.81 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.19 1.796 . . . . 1.0 112.255 -176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.02 -164.9 10.06 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.289 0.947 . . . . 1.0 114.636 -170.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -128.59 145.65 51.08 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.979 1.312 . . . . 1.0 111.752 -169.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.85 -143.66 3.77 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.626 2.06 . . . . 1.0 109.943 171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -144.5 154.38 42.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.453 1.126 . . . . 1.0 112.939 -175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.04 158.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.707 2.003 . . . . 1.0 111.584 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.96 145.26 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 126.437 1.895 . . . . 1.0 108.418 169.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.79 147.92 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.486 1.039 . . . . 1.0 109.599 169.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.51 -14.71 5.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 116.544 2.053 . . . . 1.0 116.544 -169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.8 39.56 1.12 Allowed Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.218 1.39 . . . . 1.0 114.223 170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -47.15 -26.28 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 127.486 2.314 . . . . 1.0 116.514 -169.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.74 -16.22 55.82 Favored Glycine 0 CA--C 1.543 1.818 0 C-N-CA 124.413 1.006 . . . . 1.0 115.387 171.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.46 -12.36 0.1 OUTLIER Glycine 0 CA--C 1.54 1.639 0 N-CA-C 116.864 1.506 . . . . 1.0 116.864 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.0 p -71.51 174.32 6.79 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.679 1.74 . . . . 1.0 112.741 172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.13 138.52 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.699 1.6 . . . . 1.0 109.519 -172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.1 p -70.59 151.05 45.43 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.401 1.08 . . . . 1.0 113.344 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -143.83 159.58 42.27 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.323 1.849 . . . . 1.0 110.791 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -68.97 153.32 44.0 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.672 0.389 . . . . 1.0 110.454 169.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.44 148.63 36.41 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.567 0.951 . . . . 1.0 113.567 -173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.42 153.79 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 126.526 1.93 . . . . 1.0 111.687 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.0 t -85.43 107.43 17.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.76 0.824 . . . . 1.0 111.417 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -71.9 -20.79 61.73 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.09 1.144 . . . . 1.0 114.09 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -115.63 17.31 16.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.185 1.394 . . . . 1.0 112.424 -173.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.2 m120 49.65 50.65 17.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.101 1.76 . . . . 1.0 113.191 -175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -115.37 149.1 38.47 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.195 1.398 . . . . 1.0 111.013 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.29 119.93 26.21 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -116.71 91.0 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.575 1.55 . . . . 1.0 109.364 -171.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.4 m -66.34 165.82 13.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.413 1.085 . . . . 1.0 113.439 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -50.48 140.32 14.1 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.904 1.281 . . . . 1.0 112.849 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.77 2.12 86.83 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 117.029 1.571 . . . . 1.0 117.029 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 t -94.93 158.54 15.43 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.204 2.002 . . . . 1.0 112.054 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.0 m -95.05 127.66 41.28 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.141 1.377 . . . . 1.0 109.997 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.67 145.8 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.29 1.436 . . . . 1.0 112.44 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.39 124.38 49.12 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 t -76.7 83.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 1.0 111.218 -176.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -71.03 -25.33 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.225 1.565 . . . . 1.0 115.225 -172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -149.88 166.05 30.72 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.347 1.059 . . . . 1.0 109.578 173.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -145.79 140.38 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 120.794 -1.191 . . . . 1.0 110.885 -174.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -133.77 161.84 33.61 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.17 2.188 . . . . 1.0 108.541 169.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -50.3 99.39 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.379 1.472 . . . . 1.0 114.101 -172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.03 11.49 58.59 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.664 1.602 . . . . 1.0 115.68 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -133.71 85.51 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.737 2.015 . . . . 1.0 108.47 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.66 146.89 46.24 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.69 1.196 . . . . 1.0 110.177 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.5 m -109.27 120.75 43.47 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.173 -0.954 . . . . 1.0 108.616 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.5 165.66 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 121.586 0.708 . . . . 1.0 112.277 -169.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -151.43 143.7 16.34 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.344 1.457 . . . . 1.0 108.621 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.77 122.16 9.71 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.572 2.182 . . . . 1.0 112.544 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -88.91 -37.44 15.28 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.79 1.236 . . . . 1.0 110.782 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 28.89 61.68 0.74 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 127.956 2.502 . . . . 1.0 115.251 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -69.93 163.17 39.41 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.378 2.719 . . . . 1.0 112.857 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.837 0 C-N-CA 125.035 1.334 . . . . 1.0 113.394 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.362 0 N-CA-C 114.817 0.687 . . . . 1.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 p -53.69 -35.09 60.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.225 1.41 . . . . 1.0 114.498 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -63.33 -28.33 69.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.625 0.972 . . . . 1.0 113.625 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.7 mmm -72.73 -34.49 67.1 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.279 -0.888 . . . . 1.0 111.862 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.97 -39.88 75.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.752 0.821 . . . . 1.0 111.438 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.36 -42.19 98.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.833 0.853 . . . . 1.0 112.006 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -61.44 -41.75 97.69 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.588 0.755 . . . . 1.0 111.946 172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.57 -39.43 93.73 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.483 -0.76 . . . . 1.0 112.499 176.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.93 89.64 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.719 0.807 . . . . 1.0 112.443 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.24 -42.88 92.92 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.383 -0.823 . . . . 1.0 112.11 175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.69 -36.5 84.47 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.185 -0.947 . . . . 1.0 112.294 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.4 m -62.84 -38.37 90.51 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.586 -0.696 . . . . 1.0 112.117 173.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.87 -40.53 83.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.817 0.847 . . . . 1.0 111.619 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.34 -36.43 73.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.185 0.902 . . . . 1.0 112.048 174.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -65.05 -27.64 68.93 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -76.84 -41.52 43.82 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.108 0.867 . . . . 1.0 111.729 169.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -57.19 -36.47 70.88 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.3 1.04 . . . . 1.0 111.703 173.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.71 -20.85 62.1 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.949 1.092 . . . . 1.0 113.949 175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -65.55 -30.8 71.59 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.51 1.05 . . . . 1.0 113.017 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.7 -14.27 62.31 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.366 1.067 . . . . 1.0 112.358 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -61.05 -10.67 6.4 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.671 1.188 . . . . 1.0 113.595 169.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.39 18.71 50.48 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.164 1.364 . . . . 1.0 114.171 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -133.48 158.65 42.55 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.844 1.322 . . . . 1.0 113.657 -170.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.71 156.53 19.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.05 169.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.45 -172.5 14.37 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.462 1.982 . . . . 1.0 113.175 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -143.96 117.82 9.35 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 127.889 2.476 . . . . 1.0 109.453 -169.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -74.21 122.59 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.59 0.756 . . . . 1.0 110.55 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.52 -10.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.286 1.434 . . . . 1.0 113.587 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.6 m -141.33 125.24 17.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 106.257 -1.757 . . . . 1.0 106.257 169.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 141.19 33.34 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.433 1.093 . . . . 1.0 113.919 -169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.12 95.1 49.05 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 126.151 1.781 . . . . 1.0 108.258 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.52 173.13 15.02 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.272 1.981 . . . . 1.0 112.484 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 m -53.97 -26.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 115.834 1.79 . . . . 1.0 115.834 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -142.59 31.38 1.48 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.599 1.56 . . . . 1.0 111.145 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.09 -166.08 10.56 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.678 1.132 . . . . 1.0 114.274 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -128.73 145.63 51.12 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.977 1.311 . . . . 1.0 112.218 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.84 -142.98 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.713 2.101 . . . . 1.0 110.359 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -142.63 148.61 37.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.403 1.102 . . . . 1.0 112.766 -175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -136.6 151.25 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.327 1.851 . . . . 1.0 111.019 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.25 145.89 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.566 1.946 . . . . 1.0 108.911 170.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.1 mm -69.87 153.9 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.373 -0.829 . . . . 1.0 110.052 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -54.23 -19.83 5.92 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.698 1.74 . . . . 1.0 115.698 -170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.73 47.49 2.78 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.224 1.392 . . . . 1.0 112.574 169.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 pp -47.57 -26.81 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 127.424 2.289 . . . . 1.0 115.829 -169.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.37 -5.48 79.32 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.254 1.406 . . . . 1.0 115.297 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.93 28.15 1.87 Allowed Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.967 1.746 . . . . 1.0 113.705 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 25.7 p -136.56 179.2 6.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.248 2.219 . . . . 1.0 110.841 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.82 127.12 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.175 1.39 . . . . 1.0 108.717 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 p -68.8 151.45 46.61 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.217 1.007 . . . . 1.0 112.865 176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -140.38 159.55 41.94 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.454 1.902 . . . . 1.0 110.444 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -64.77 150.08 48.1 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.011 0.525 . . . . 1.0 111.062 170.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.87 145.81 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.558 0.948 . . . . 1.0 113.558 -172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.34 156.32 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 126.537 1.935 . . . . 1.0 111.6 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -75.37 122.06 23.19 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.452 -0.78 . . . . 1.0 111.09 173.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -77.72 -20.64 53.19 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.162 0.801 . . . . 1.0 113.162 170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -115.89 10.92 15.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.742 1.217 . . . . 1.0 113.273 -169.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.67 44.15 24.21 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.198 1.799 . . . . 1.0 112.361 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -117.3 153.49 32.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.016 1.726 . . . . 1.0 110.84 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.45 129.53 34.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -126.03 83.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.007 1.323 . . . . 1.0 108.225 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -64.37 166.35 8.33 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.59 1.156 . . . . 1.0 112.628 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -51.08 141.15 14.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.962 1.305 . . . . 1.0 113.616 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.74 38.35 37.09 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.946 1.139 . . . . 1.0 115.946 169.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 t -127.18 154.55 44.65 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 118.795 1.297 . . . . 1.0 112.312 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 29.4 m -93.2 126.49 38.33 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.007 0.923 . . . . 1.0 110.295 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -127.8 145.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.46 1.504 . . . . 1.0 111.179 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.2 tp -91.52 126.35 36.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.027 -1.101 . . . . 1.0 108.027 169.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.2 t -74.88 120.16 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 107.924 -1.139 . . . . 1.0 107.924 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.05 -19.51 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.515 1.126 . . . . 1.0 113.919 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -149.49 160.13 43.72 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.914 1.286 . . . . 1.0 108.786 169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 mt -147.88 132.47 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.976 0.91 . . . . 1.0 110.054 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.51 83.72 1.87 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.198 1.399 . . . . 1.0 111.346 -175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.2 t30 41.89 55.61 3.68 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 126.442 1.897 . . . . 1.0 115.348 169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.14 -7.0 58.4 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.022 1.296 . . . . 1.0 114.552 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.65 96.96 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.101 1.76 . . . . 1.0 108.313 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.21 146.39 31.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.609 1.163 . . . . 1.0 109.928 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -108.96 123.11 48.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.804 1.241 . . . . 1.0 108.125 171.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.99 162.81 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.369 0.604 . . . . 1.0 112.316 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -145.26 140.79 16.37 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.65 1.18 . . . . 1.0 110.279 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.71 92.89 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.377 2.718 . . . . 1.0 112.765 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -70.36 -37.08 74.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 1.0 111.573 176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 38.29 56.2 4.81 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 126.33 1.852 . . . . 1.0 114.939 -175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -68.24 161.37 44.9 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.313 2.675 . . . . 1.0 112.801 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 125.675 1.59 . . . . 1.0 112.759 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.318 0 N-CA-C 114.842 0.697 . . . . 1.0 114.842 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.8 p -55.83 -33.72 64.74 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.817 1.247 . . . . 1.0 114.034 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -63.42 -27.21 69.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.716 1.006 . . . . 1.0 113.716 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -72.63 -37.29 68.08 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.351 -0.843 . . . . 1.0 111.604 172.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.43 -35.28 75.54 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.2 1.0 . . . . 1.0 111.879 174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -66.45 -41.72 88.69 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.319 -0.863 . . . . 1.0 111.697 169.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -63.06 -41.93 99.57 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.708 -0.62 . . . . 1.0 112.177 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.52 -36.85 81.84 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 1.0 113.044 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.3 93.82 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 118.908 0.776 . . . . 1.0 112.408 173.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.52 -37.8 85.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.813 0.845 . . . . 1.0 112.677 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -66.47 -37.41 85.05 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.046 -1.034 . . . . 1.0 111.958 172.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.0 m -65.04 -39.09 92.82 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.469 -0.77 . . . . 1.0 111.698 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 tt -63.66 -44.54 93.5 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.349 0.659 . . . . 1.0 110.906 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.99 79.14 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 118.673 0.67 . . . . 1.0 112.332 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -65.79 -43.53 88.48 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.731 0.813 . . . . 1.0 112.605 173.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -61.85 -40.5 95.57 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.431 -0.793 . . . . 1.0 112.286 171.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -64.24 -40.58 96.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.556 0.743 . . . . 1.0 111.557 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -64.83 -23.99 67.41 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.97 -30.5 71.5 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.774 1.17 . . . . 1.0 112.477 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.29 -14.37 61.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.322 1.049 . . . . 1.0 112.863 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttp85 -64.71 -10.93 30.78 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.976 1.71 . . . . 1.0 113.804 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.76 20.1 42.48 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.237 1.399 . . . . 1.0 113.839 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -131.55 161.37 32.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.998 1.319 . . . . 1.0 113.321 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.67 157.11 19.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.438 1.095 . . . . 1.0 110.467 170.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.1 -171.21 12.94 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.613 2.054 . . . . 1.0 113.842 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 118.2 9.26 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.184 2.594 . . . . 1.0 110.047 -169.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.66 132.02 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.84 0.856 . . . . 1.0 111.631 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -16.08 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 124.9 1.28 . . . . 1.0 114.261 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -135.42 125.97 26.93 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 106.924 -1.51 . . . . 1.0 106.924 172.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.62 134.5 41.36 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.141 0.976 . . . . 1.0 113.53 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.7 t -112.33 93.47 22.62 Favored Pre-proline 0 N--CA 1.47 0.53 0 C-N-CA 126.623 1.969 . . . . 1.0 107.844 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.47 172.55 16.1 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.429 2.086 . . . . 1.0 112.752 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -54.32 -27.58 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.144 1.778 . . . . 1.0 115.556 -170.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -142.62 31.58 1.47 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.438 1.495 . . . . 1.0 111.147 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.67 -163.08 9.37 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.634 1.111 . . . . 1.0 114.233 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -128.76 145.55 51.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.905 1.282 . . . . 1.0 112.323 -169.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.86 -144.12 3.88 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.586 2.041 . . . . 1.0 110.294 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -144.35 147.58 33.63 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.487 1.143 . . . . 1.0 113.223 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.47 154.89 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.621 2.368 . . . . 1.0 110.305 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.38 145.17 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.618 1.967 . . . . 1.0 108.02 169.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.3 mm -71.62 149.76 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 119.638 1.108 . . . . 1.0 110.214 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -57.72 -15.58 8.37 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.37 1.989 . . . . 1.0 116.37 -169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.67 40.95 0.8 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.686 1.612 . . . . 1.0 114.505 170.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.23 -22.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 127.568 2.347 . . . . 1.0 116.92 -169.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.18 -16.58 62.54 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.398 0.999 . . . . 1.0 115.041 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.7 -10.52 0.09 OUTLIER Glycine 0 CA--C 1.542 1.729 0 N-CA-C 117.016 1.566 . . . . 1.0 117.016 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -71.05 171.91 10.06 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 119.755 1.777 . . . . 1.0 113.086 173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.01 138.57 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.661 1.584 . . . . 1.0 109.729 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 p -70.31 150.72 46.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.437 1.095 . . . . 1.0 113.273 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -143.63 159.27 42.76 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.292 1.837 . . . . 1.0 110.529 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -65.54 151.19 47.01 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.302 0.641 . . . . 1.0 111.027 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.56 36.6 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.639 0.977 . . . . 1.0 113.639 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.06 156.61 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 127.008 2.123 . . . . 1.0 111.619 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -75.78 121.66 22.9 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.502 -0.748 . . . . 1.0 111.161 172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -78.48 -17.74 55.85 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.765 0.826 . . . . 1.0 113.054 170.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -118.57 12.03 13.05 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.016 1.327 . . . . 1.0 113.195 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 55.7 43.16 28.46 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.039 1.736 . . . . 1.0 112.906 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -115.87 151.46 35.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.059 1.743 . . . . 1.0 110.996 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -83.18 131.93 35.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 170.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.23 89.68 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.961 1.305 . . . . 1.0 108.756 -175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.9 m -68.43 169.46 10.73 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.452 1.101 . . . . 1.0 112.495 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -48.9 141.02 8.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.14 1.376 . . . . 1.0 113.402 173.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.86 42.57 20.2 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 116.783 1.473 . . . . 1.0 116.783 169.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 t -133.91 158.28 43.86 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.196 1.498 . . . . 1.0 112.77 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -89.85 127.44 35.99 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.452 1.101 . . . . 1.0 110.485 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.14 145.19 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.511 1.524 . . . . 1.0 110.553 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 tp -95.14 126.56 40.55 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.417 -0.802 . . . . 1.0 108.86 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -82.4 74.78 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.981 0.913 . . . . 1.0 110.09 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 m -66.92 -22.4 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.107 1.521 . . . . 1.0 115.107 -171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.97 164.55 34.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.415 1.007 . . . . 1.0 111.073 169.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.8 mt -145.86 136.2 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.699 1.2 . . . . 1.0 110.246 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.24 83.56 1.92 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.499 1.519 . . . . 1.0 111.116 -176.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 45.11 50.61 9.32 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.126 1.77 . . . . 1.0 115.085 169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.36 -6.6 57.85 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.926 1.251 . . . . 1.0 114.631 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.35 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.988 1.715 . . . . 1.0 108.307 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.52 150.26 39.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.831 1.252 . . . . 1.0 110.263 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 m -113.56 119.9 39.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.282 -1.377 . . . . 1.0 107.282 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.9 m -131.27 163.27 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.426 0.631 . . . . 1.0 112.156 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.9 t -148.28 140.98 15.0 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.722 1.209 . . . . 1.0 109.508 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.89 92.44 0.8 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.807 2.338 . . . . 1.0 112.422 -175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -63.55 -34.83 78.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.256 1.022 . . . . 1.0 111.487 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 35.18 61.14 2.46 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 127.172 2.189 . . . . 1.0 114.787 -177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -53.38 146.52 40.82 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.539 2.826 . . . . 1.0 114.067 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.471 0.613 0 C-N-CA 126.162 1.785 . . . . 1.0 112.784 -177.423 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.352 0 N-CA-C 114.804 0.681 . . . . 1.0 114.804 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -55.42 -30.45 60.48 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.098 1.359 . . . . 1.0 114.098 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -58.26 -32.56 68.49 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.738 1.014 . . . . 1.0 113.738 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 mmt -72.55 -35.83 68.1 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.171 0.896 . . . . 1.0 112.295 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.74 -40.93 75.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.849 0.86 . . . . 1.0 111.227 176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.16 -40.52 96.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.486 1.114 . . . . 1.0 112.137 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -62.95 -41.08 99.41 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.678 -0.639 . . . . 1.0 111.83 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.5 m -64.68 -39.16 93.2 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.542 0.737 . . . . 1.0 112.293 176.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.44 91.41 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.641 0.776 . . . . 1.0 112.419 173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.99 -41.35 95.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.754 0.822 . . . . 1.0 112.334 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.52 -34.64 78.37 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.282 -0.886 . . . . 1.0 112.541 173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.6 m -66.35 -38.99 88.86 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.548 -0.72 . . . . 1.0 111.743 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -65.03 -43.04 93.73 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.501 -0.75 . . . . 1.0 110.741 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.7 74.75 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.698 0.681 . . . . 1.0 112.348 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -67.64 -42.54 82.12 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.539 0.736 . . . . 1.0 112.757 172.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -61.13 -38.43 86.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.639 0.776 . . . . 1.0 112.341 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.18 -41.55 85.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.854 0.862 . . . . 1.0 112.157 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.66 -25.98 68.46 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.495 1.043 . . . . 1.0 113.368 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.46 -30.31 70.51 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.921 -1.112 . . . . 1.0 112.68 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.91 -14.7 55.62 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.924 0.889 . . . . 1.0 112.923 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -62.82 -10.91 14.82 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.639 1.176 . . . . 1.0 113.461 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.67 17.28 55.23 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.793 1.187 . . . . 1.0 113.836 171.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -131.47 159.43 38.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.846 1.323 . . . . 1.0 113.707 -170.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.11 150.15 21.75 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.002 2.121 . . . . 1.0 109.549 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.32 -174.24 15.46 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.08 1.8 . . . . 1.0 114.213 -174.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -144.05 116.11 8.38 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 127.524 2.33 . . . . 1.0 109.428 -170.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.1 134.87 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.71 0.804 . . . . 1.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.51 -13.53 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.872 1.669 . . . . 1.0 113.397 -173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 93.6 m -140.76 127.43 20.27 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 105.778 -1.934 . . . . 1.0 105.778 169.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.12 139.79 46.11 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.607 0.966 . . . . 1.0 113.607 -169.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.0 t -119.57 94.24 48.23 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.36 1.864 . . . . 1.0 108.528 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.76 172.79 15.57 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.251 1.967 . . . . 1.0 112.975 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -54.77 -24.37 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 115.639 1.718 . . . . 1.0 115.639 -171.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -143.62 30.83 1.33 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.549 1.54 . . . . 1.0 111.241 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.06 -164.29 9.87 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.46 1.029 . . . . 1.0 114.517 -173.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -128.53 145.58 51.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.999 1.32 . . . . 1.0 112.214 -169.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -150.01 -143.27 3.71 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 126.799 2.142 . . . . 1.0 109.958 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -144.15 154.52 43.25 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.609 1.204 . . . . 1.0 113.096 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.9 p -144.7 158.09 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.511 1.924 . . . . 1.0 111.625 -176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.98 145.22 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.345 1.858 . . . . 1.0 108.331 169.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.1 mm -71.79 148.22 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 119.495 1.043 . . . . 1.0 109.871 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -58.33 -14.08 6.67 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.669 2.1 . . . . 1.0 116.669 -169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.44 40.57 0.92 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.425 1.488 . . . . 1.0 114.01 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 pp -47.81 -22.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 127.746 2.419 . . . . 1.0 117.03 -169.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.79 -16.16 65.55 Favored Glycine 0 CA--C 1.541 1.672 0 C-N-CA 124.494 1.045 . . . . 1.0 115.068 171.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.76 -9.94 0.1 OUTLIER Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.984 1.554 . . . . 1.0 116.984 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.6 p -70.98 175.07 5.43 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 119.694 1.747 . . . . 1.0 112.995 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -128.71 136.43 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.859 1.663 . . . . 1.0 109.574 -171.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.0 p -71.47 147.97 47.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.068 0.947 . . . . 1.0 112.842 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -141.81 160.6 39.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.285 1.834 . . . . 1.0 110.796 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.3 t -68.45 151.45 46.81 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.959 -0.385 . . . . 1.0 109.959 169.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.33 148.19 37.55 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.69 0.996 . . . . 1.0 113.69 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -129.0 153.87 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 126.524 1.93 . . . . 1.0 111.45 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 t -84.74 106.62 16.42 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.723 0.809 . . . . 1.0 111.565 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -66.18 -32.2 73.5 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.025 0.93 . . . . 1.0 113.145 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -101.88 17.33 23.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.147 1.379 . . . . 1.0 112.512 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . 0.272 0.9 OUTLIER 45.94 44.91 11.72 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.88 2.072 . . . . 1.0 114.458 -174.054 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -106.59 153.47 22.3 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.19 1.396 . . . . 1.0 110.923 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 123.71 29.53 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 170.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.97 93.33 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.225 1.41 . . . . 1.0 108.874 -173.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -68.99 170.26 10.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.277 0.843 . . . . 1.0 113.277 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -52.68 142.26 18.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.33 1.452 . . . . 1.0 112.755 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.57 31.99 60.08 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 118.729 -1.039 . . . . 1.0 115.659 169.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 t -121.06 153.95 36.73 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.186 1.493 . . . . 1.0 112.474 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.9 m -92.99 124.53 37.03 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.779 1.232 . . . . 1.0 110.156 -172.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.7 m -128.72 145.65 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.15 1.38 . . . . 1.0 112.311 -169.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.98 127.64 42.18 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 169.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.2 t -74.22 125.3 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.71 -19.86 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.712 1.205 . . . . 1.0 113.829 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.34 162.48 40.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.493 1.517 . . . . 1.0 107.929 168.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.8 mt -147.0 140.29 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.052 -1.03 . . . . 1.0 110.981 -172.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -134.89 161.77 34.3 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.381 2.273 . . . . 1.0 108.429 169.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -50.42 99.11 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.653 1.581 . . . . 1.0 113.762 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 9.88 59.29 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.709 1.623 . . . . 1.0 115.802 -176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 t -133.02 87.89 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.111 2.164 . . . . 1.0 108.583 -177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mp -76.81 149.33 36.22 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.933 1.293 . . . . 1.0 110.427 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.0 m -108.69 121.31 44.76 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.324 1.05 . . . . 1.0 108.585 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.23 162.9 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.546 0.739 . . . . 1.0 112.49 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -144.37 141.67 18.39 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.64 1.176 . . . . 1.0 110.471 175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.88 91.32 0.72 Allowed 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 123.331 2.687 . . . . 1.0 112.742 -176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -38.25 87.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.738 1.215 . . . . 1.0 111.883 176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 36.28 56.3 3.04 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.551 1.94 . . . . 1.0 115.295 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.59 159.28 54.24 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.266 2.644 . . . . 1.0 112.656 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.8 mt . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 125.709 1.604 . . . . 1.0 109.769 -179.375 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 114.486 0.555 . . . . 1.0 114.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 p -57.3 -36.49 71.15 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.43 1.115 . . . . 1.0 112.924 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -59.04 -31.25 68.68 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.848 1.259 . . . . 1.0 113.75 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mmm -74.86 -35.89 62.35 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.302 -0.874 . . . . 1.0 111.876 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.0 mt -67.87 -41.04 83.47 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.604 0.762 . . . . 1.0 111.422 174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.12 -43.37 98.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.85 0.86 . . . . 1.0 111.889 171.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -60.67 -40.87 93.71 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.709 -0.62 . . . . 1.0 111.937 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -64.91 -38.56 91.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.672 0.789 . . . . 1.0 112.429 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 -41.18 88.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.544 0.738 . . . . 1.0 112.414 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -39.49 89.56 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.326 -0.859 . . . . 1.0 112.583 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.01 -38.86 92.35 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.239 -0.913 . . . . 1.0 112.041 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.9 m -62.63 -39.29 93.36 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.632 -0.667 . . . . 1.0 111.881 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.51 -43.26 94.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.499 0.719 . . . . 1.0 110.927 173.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.73 75.02 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 118.935 0.789 . . . . 1.0 112.416 174.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -68.52 -38.48 80.93 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.536 -0.727 . . . . 1.0 112.73 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -64.4 -39.66 94.29 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.463 -0.773 . . . . 1.0 112.248 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.21 -41.49 90.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.765 0.826 . . . . 1.0 111.82 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -60.27 -29.6 68.91 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.243 -0.911 . . . . 1.0 113.174 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -61.26 -30.04 70.22 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.205 -0.934 . . . . 1.0 112.775 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.5 mt -68.07 -12.63 61.19 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.725 1.21 . . . . 1.0 113.556 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 -61.7 -13.6 24.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.284 1.034 . . . . 1.0 113.549 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.63 17.32 56.75 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.038 1.304 . . . . 1.0 114.286 171.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -128.87 159.36 36.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.931 1.365 . . . . 1.0 113.95 -174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.8 tp -94.82 151.02 19.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.793 2.437 . . . . 1.0 109.787 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.39 -173.16 14.12 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.033 1.778 . . . . 1.0 114.848 -175.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.48 116.61 8.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.835 2.454 . . . . 1.0 109.594 -169.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.5 t -74.31 135.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.941 0.896 . . . . 1.0 111.329 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.41 -15.07 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.893 1.677 . . . . 1.0 113.591 -173.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.3 m -139.03 127.71 23.29 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 105.767 -1.938 . . . . 1.0 105.767 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.24 137.48 47.22 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.97 0.908 . . . . 1.0 113.351 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.7 t -116.96 92.85 40.29 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 126.238 1.815 . . . . 1.0 108.174 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.33 172.39 16.16 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.239 1.959 . . . . 1.0 112.869 -176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.9 m -53.74 -27.91 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.954 1.702 . . . . 1.0 115.457 -170.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -142.18 31.26 1.56 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.602 1.561 . . . . 1.0 111.089 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.79 -163.57 9.56 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.623 1.106 . . . . 1.0 114.218 -174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -128.67 145.57 51.12 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.913 1.285 . . . . 1.0 112.25 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.65 -143.63 3.79 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.476 1.988 . . . . 1.0 110.13 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -143.86 154.83 43.78 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.43 1.115 . . . . 1.0 113.057 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.08 157.98 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.676 1.99 . . . . 1.0 111.403 -176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.84 145.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 126.485 1.914 . . . . 1.0 108.471 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.8 mm -71.4 149.05 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.789 1.177 . . . . 1.0 109.902 170.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.42 -15.68 7.35 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.477 2.029 . . . . 1.0 116.477 -169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.87 41.01 0.84 Allowed Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.587 1.565 . . . . 1.0 114.414 170.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 pp -48.24 -22.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 127.611 2.364 . . . . 1.0 116.955 -169.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.15 64.06 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 124.47 1.033 . . . . 1.0 114.977 171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.73 -10.7 0.09 OUTLIER Glycine 0 CA--C 1.541 1.693 0 N-CA-C 117.031 1.573 . . . . 1.0 117.031 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.3 p -70.74 172.05 9.42 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.722 1.761 . . . . 1.0 112.946 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.71 135.72 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.43 1.492 . . . . 1.0 109.88 -171.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 m -66.89 149.28 50.82 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.926 1.29 . . . . 1.0 113.03 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.51 161.86 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.996 1.718 . . . . 1.0 111.351 177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -67.74 151.65 46.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.57 0.748 . . . . 1.0 111.104 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.19 38.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.08 151.96 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 126.73 2.012 . . . . 1.0 111.944 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 t -85.06 102.79 13.52 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.029 0.931 . . . . 1.0 111.262 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -66.66 -31.8 72.71 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.039 0.755 . . . . 1.0 113.039 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -95.42 12.02 30.78 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.786 1.234 . . . . 1.0 112.803 -175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 55.79 43.16 28.22 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.752 1.621 . . . . 1.0 112.695 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -115.24 155.03 27.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.897 1.679 . . . . 1.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.0 118.0 27.26 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.23 91.93 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 125.246 1.418 . . . . 1.0 109.388 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.6 m -65.1 166.63 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.318 1.047 . . . . 1.0 113.342 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -50.86 142.43 11.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.865 1.266 . . . . 1.0 112.195 169.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.89 34.59 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 116.088 1.195 . . . . 1.0 116.088 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.51 157.71 40.43 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 119.209 1.504 . . . . 1.0 113.074 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.9 m -91.94 125.73 36.75 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 1.0 110.594 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -130.94 145.78 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.281 1.433 . . . . 1.0 112.035 -169.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.9 tp -96.77 129.21 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.335 -0.853 . . . . 1.0 109.547 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.84 76.78 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.806 0.842 . . . . 1.0 110.079 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 p -61.81 -31.47 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.146 1.378 . . . . 1.0 114.619 -171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -148.31 165.41 31.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.303 1.441 . . . . 1.0 110.838 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 mt -145.15 139.33 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.632 1.173 . . . . 1.0 110.31 -174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -141.96 83.22 1.83 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.537 1.535 . . . . 1.0 111.296 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 66.4 t30 42.75 54.56 4.58 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.44 1.896 . . . . 1.0 115.649 169.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.07 -12.58 57.43 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.234 1.397 . . . . 1.0 114.163 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.52 95.03 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.075 1.75 . . . . 1.0 108.175 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -74.16 147.84 42.25 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.377 1.071 . . . . 1.0 109.967 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.8 m -108.85 123.21 48.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.888 1.275 . . . . 1.0 107.615 172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 m -133.08 160.64 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 121.564 0.697 . . . . 1.0 111.777 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.1 t -147.01 139.47 14.1 Favored Pre-proline 0 N--CA 1.47 0.533 0 C-N-CA 125.0 1.32 . . . . 1.0 109.3 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.11 90.63 0.86 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.853 2.369 . . . . 1.0 112.462 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.57 -37.02 77.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.834 1.253 . . . . 1.0 111.419 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.15 54.27 3.09 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 127.206 2.203 . . . . 1.0 115.236 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.96 157.74 60.67 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.178 2.585 . . . . 1.0 112.543 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 125.758 1.623 . . . . 1.0 109.818 -178.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 N-CA-C 114.843 0.697 . . . . 1.0 114.843 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 m -55.59 -30.68 61.29 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.149 1.38 . . . . 1.0 114.387 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -60.15 -34.35 73.43 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.983 0.735 . . . . 1.0 112.983 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.1 tpt -71.35 -36.7 71.61 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.211 -0.931 . . . . 1.0 111.915 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.35 -41.65 89.23 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.351 0.66 . . . . 1.0 111.354 174.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.6 -42.86 98.21 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.987 0.915 . . . . 1.0 112.024 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -60.59 -41.71 95.27 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.248 0.619 . . . . 1.0 111.8 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 t -63.44 -42.06 98.66 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.004 0.922 . . . . 1.0 112.173 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.96 97.23 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.477 -0.765 . . . . 1.0 112.72 174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.01 -38.42 85.95 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.34 -0.85 . . . . 1.0 112.81 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.3 -35.94 80.49 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.11 -0.994 . . . . 1.0 112.373 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -64.41 -41.44 96.63 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.647 -0.658 . . . . 1.0 111.402 171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -61.79 -44.09 97.57 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.453 -0.779 . . . . 1.0 111.099 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.36 -36.88 79.05 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.736 0.698 . . . . 1.0 112.548 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -67.22 -44.44 79.52 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.512 0.725 . . . . 1.0 112.495 173.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.6 mtm-85 -60.96 -38.63 86.55 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.465 0.706 . . . . 1.0 112.315 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -67.08 -42.65 84.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.974 0.91 . . . . 1.0 111.691 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -64.95 -27.12 68.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.476 1.035 . . . . 1.0 113.497 174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -61.76 -30.29 70.69 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 120.847 -1.158 . . . . 1.0 112.693 169.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 mt -63.17 -14.59 50.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.871 0.868 . . . . 1.0 112.892 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -62.62 -10.62 12.91 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.695 1.198 . . . . 1.0 113.594 170.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.29 18.1 49.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.826 1.203 . . . . 1.0 113.84 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -131.33 159.61 37.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.826 1.25 . . . . 1.0 113.627 -170.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.08 149.11 22.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.004 2.121 . . . . 1.0 109.566 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.36 -174.57 14.99 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.187 1.851 . . . . 1.0 114.055 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -145.11 116.24 7.9 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.172 2.189 . . . . 1.0 109.709 -169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.28 134.78 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.042 0.937 . . . . 1.0 111.29 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.46 -10.18 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 125.979 1.712 . . . . 1.0 113.372 -173.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.7 m -143.74 127.09 16.75 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 105.801 -1.925 . . . . 1.0 105.801 169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.65 141.18 44.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.848 0.859 . . . . 1.0 113.105 -169.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -118.61 95.18 48.64 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.623 1.569 . . . . 1.0 107.712 -173.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.33 170.67 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.232 1.954 . . . . 1.0 112.505 -176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.31 -20.32 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -169.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -145.54 31.19 1.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.63 1.572 . . . . 1.0 111.316 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.56 -160.97 8.57 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.506 1.05 . . . . 1.0 114.496 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -128.64 145.87 51.03 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.891 1.277 . . . . 1.0 112.869 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.62 -143.66 3.83 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 126.979 2.228 . . . . 1.0 110.1 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -144.07 155.36 43.94 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.617 1.208 . . . . 1.0 113.125 -175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.99 158.03 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.659 1.983 . . . . 1.0 111.519 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -128.85 145.35 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 126.205 1.802 . . . . 1.0 108.072 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.49 147.73 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.587 1.085 . . . . 1.0 109.722 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -58.21 -14.41 7.04 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.736 2.125 . . . . 1.0 116.736 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.97 41.33 1.06 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.402 1.477 . . . . 1.0 113.783 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 1.8 pp -47.36 -22.84 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 127.753 2.421 . . . . 1.0 117.057 -169.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.24 -16.19 66.58 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 124.478 1.037 . . . . 1.0 115.085 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.97 -8.52 0.1 Allowed Glycine 0 CA--C 1.54 1.637 0 N-CA-C 117.053 1.581 . . . . 1.0 117.053 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -71.76 178.23 3.74 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 119.576 1.688 . . . . 1.0 113.027 173.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.71 134.03 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.743 1.617 . . . . 1.0 109.737 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.2 m -70.06 143.76 52.38 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.079 0.951 . . . . 1.0 111.942 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -140.53 158.39 44.07 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.008 1.723 . . . . 1.0 110.728 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.9 m -69.72 153.33 43.54 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.013 -0.429 . . . . 1.0 110.309 169.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.67 150.39 38.64 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.756 1.021 . . . . 1.0 113.756 -173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.23 154.18 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.905 2.082 . . . . 1.0 110.809 172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 t -78.9 122.58 26.29 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.468 -0.77 . . . . 1.0 111.14 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -78.43 -12.56 60.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.296 1.038 . . . . 1.0 113.167 171.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -124.52 16.3 8.88 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.373 1.469 . . . . 1.0 112.686 -169.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.8 m120 47.56 46.61 17.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.648 1.979 . . . . 1.0 113.822 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -104.46 155.8 18.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.449 1.5 . . . . 1.0 111.33 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -96.1 82.81 3.53 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.217 1.007 . . . . 1.0 109.032 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mt -79.39 96.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.3 1.44 . . . . 1.0 109.53 -169.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.93 170.33 12.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.936 0.874 . . . . 1.0 113.108 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -54.41 141.41 30.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.559 1.544 . . . . 1.0 112.855 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.33 28.11 64.54 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 116.009 1.164 . . . . 1.0 116.009 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 t -115.91 153.74 31.02 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.271 1.536 . . . . 1.0 112.429 178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.2 m -93.37 125.33 37.92 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.72 1.208 . . . . 1.0 110.301 -172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.3 m -128.88 145.57 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.406 1.482 . . . . 1.0 112.33 -169.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 tp -95.31 127.73 41.59 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.59 125.5 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.013 -1.106 . . . . 1.0 108.013 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.8 m -120.78 -20.67 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.687 1.195 . . . . 1.0 113.783 -169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -150.27 162.74 39.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.534 1.534 . . . . 1.0 107.963 169.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.9 mt -147.15 140.24 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.982 -1.074 . . . . 1.0 110.852 -172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -132.98 163.0 30.18 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 127.439 2.295 . . . . 1.0 108.506 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -50.25 99.28 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.303 1.441 . . . . 1.0 114.097 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.86 11.45 57.95 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.645 1.593 . . . . 1.0 115.709 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.54 89.2 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.774 2.03 . . . . 1.0 108.617 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.38 148.92 33.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.749 1.22 . . . . 1.0 110.473 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m -108.44 120.97 43.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.445 1.098 . . . . 1.0 108.629 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.42 162.71 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.301 0.64 . . . . 1.0 112.671 -169.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -143.24 141.01 18.42 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.606 1.162 . . . . 1.0 110.449 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.13 91.09 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.486 2.791 . . . . 1.0 112.855 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.85 -38.52 89.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.903 1.281 . . . . 1.0 111.923 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 36.05 56.42 2.91 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 126.637 1.975 . . . . 1.0 115.26 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.58 158.73 56.5 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.16 2.573 . . . . 1.0 112.571 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 N--CA 1.476 0.854 0 C-N-CA 126.042 1.737 . . . . 1.0 109.97 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 114.458 0.543 . . . . 1.0 114.458 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.5 p -56.79 -40.59 76.2 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.516 1.158 . . . . 1.0 112.697 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -57.77 -37.46 73.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.152 1.381 . . . . 1.0 113.344 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ttt -72.35 -40.38 67.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.426 -0.796 . . . . 1.0 111.709 176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.39 -35.89 82.3 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.674 0.79 . . . . 1.0 112.466 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -68.25 -41.45 81.14 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.187 -0.946 . . . . 1.0 111.917 170.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -61.21 -43.97 98.03 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.219 0.608 . . . . 1.0 111.893 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.3 p -67.31 -36.74 82.11 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.403 -0.811 . . . . 1.0 112.816 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.37 -41.68 96.57 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.976 0.807 . . . . 1.0 112.626 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.87 -40.33 91.55 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.319 -0.863 . . . . 1.0 112.57 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -66.89 -34.58 78.1 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.13 -0.981 . . . . 1.0 112.565 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.9 m -66.04 -39.31 90.06 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.499 -0.75 . . . . 1.0 111.774 172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.48 -43.36 94.41 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.461 -0.774 . . . . 1.0 110.771 173.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 -36.79 75.93 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.563 -0.711 . . . . 1.0 112.337 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -67.76 -41.72 82.89 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.677 0.791 . . . . 1.0 112.723 172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -61.14 -39.71 91.11 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 121.367 -0.833 . . . . 1.0 112.277 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -66.96 -41.04 87.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.619 0.768 . . . . 1.0 112.008 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.76 -30.01 71.12 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.084 -1.01 . . . . 1.0 113.353 175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.11 -30.57 69.36 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.202 -0.936 . . . . 1.0 112.757 170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.92 -14.7 63.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.968 0.907 . . . . 1.0 113.126 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -62.37 -13.58 30.71 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.88 1.272 . . . . 1.0 113.383 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.6 20.1 47.75 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.286 1.422 . . . . 1.0 114.184 174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -132.71 161.92 32.76 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.825 1.313 . . . . 1.0 113.648 -171.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.11 154.37 20.52 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.426 1.09 . . . . 1.0 110.021 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -138.48 -172.91 12.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 126.609 2.052 . . . . 1.0 113.02 172.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -145.8 117.84 8.29 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 127.48 2.312 . . . . 1.0 109.446 -169.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.4 127.95 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.245 1.018 . . . . 1.0 111.285 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -6.86 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.484 1.513 . . . . 1.0 113.801 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.6 m -143.35 125.96 15.92 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 169.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.55 141.07 38.58 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.154 0.982 . . . . 1.0 113.35 -169.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.5 t -117.69 93.85 44.59 Favored Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 125.299 1.44 . . . . 1.0 107.747 -175.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -71.25 171.01 16.89 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.345 2.03 . . . . 1.0 112.375 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -56.9 -20.15 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 115.558 1.688 . . . . 1.0 115.558 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.47 31.08 1.09 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.619 1.568 . . . . 1.0 111.415 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.74 -162.02 8.99 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.478 1.037 . . . . 1.0 114.636 -172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -128.69 145.85 51.05 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.087 1.355 . . . . 1.0 112.609 -169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.72 -143.62 3.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.565 2.031 . . . . 1.0 110.615 171.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -142.55 149.8 39.56 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.377 1.089 . . . . 1.0 112.75 -174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.34 155.72 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.009 1.723 . . . . 1.0 111.269 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.34 146.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 127.474 2.31 . . . . 1.0 107.554 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.62 151.76 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 119.172 0.897 . . . . 1.0 109.582 171.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -53.64 -15.17 1.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 117.38 2.363 . . . . 1.0 117.38 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.63 42.38 1.27 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.041 1.305 . . . . 1.0 113.106 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.3 pp -46.9 -26.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 128.063 2.545 . . . . 1.0 116.189 -169.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.95 -14.6 65.91 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.416 1.007 . . . . 1.0 115.286 173.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.52 -7.17 0.13 Allowed Glycine 0 CA--C 1.54 1.605 0 N-CA-C 116.888 1.515 . . . . 1.0 116.888 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.3 p -68.91 175.34 3.73 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.736 1.768 . . . . 1.0 113.13 171.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 88.2 mt -128.24 130.35 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.783 1.633 . . . . 1.0 108.108 -170.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -71.35 152.67 42.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.742 0.782 . . . . 1.0 112.737 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -143.09 158.73 43.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.617 1.967 . . . . 1.0 110.009 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.6 m -67.0 151.54 47.47 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.877 0.471 . . . . 1.0 110.846 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.28 147.64 38.53 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.594 0.961 . . . . 1.0 113.594 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.15 150.11 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 126.523 1.929 . . . . 1.0 111.372 172.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.3 t -78.38 120.69 23.49 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.69 -0.631 . . . . 1.0 110.606 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -80.91 -9.16 59.86 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.214 0.82 . . . . 1.0 113.214 172.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -124.11 15.56 9.17 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.337 1.455 . . . . 1.0 112.408 -170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 33.8 m120 46.84 45.4 15.02 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.846 2.059 . . . . 1.0 113.862 -175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -102.81 154.0 19.61 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.006 1.322 . . . . 1.0 110.96 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -90.76 89.55 7.55 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 170.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mt -83.1 82.24 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.592 1.157 . . . . 1.0 108.821 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.9 m -60.89 164.35 4.94 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.492 1.117 . . . . 1.0 112.637 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -50.85 140.34 15.29 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.194 1.398 . . . . 1.0 113.85 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.45 40.52 27.7 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 116.292 1.277 . . . . 1.0 116.292 169.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -128.76 155.15 45.57 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.922 1.361 . . . . 1.0 112.48 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.9 m -91.21 130.15 37.12 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.331 1.052 . . . . 1.0 110.119 -175.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.01 145.47 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.668 1.587 . . . . 1.0 111.186 -169.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -94.87 125.33 39.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.166 0.986 . . . . 1.0 108.717 173.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.69 76.8 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.13 0.972 . . . . 1.0 110.556 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.69 -31.45 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 114.496 1.295 . . . . 1.0 114.496 -170.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -147.68 164.06 34.71 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.975 1.31 . . . . 1.0 111.066 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -144.34 137.94 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.841 1.256 . . . . 1.0 109.908 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -143.3 88.67 2.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.093 1.357 . . . . 1.0 111.315 -178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.9 t30 41.85 54.1 3.97 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 126.494 1.917 . . . . 1.0 115.504 171.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.23 -8.19 62.56 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.725 1.155 . . . . 1.0 114.806 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.35 98.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.052 1.741 . . . . 1.0 108.243 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.73 146.77 35.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.705 1.202 . . . . 1.0 110.006 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.2 m -108.55 123.39 48.84 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.057 1.343 . . . . 1.0 107.894 171.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.08 161.02 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.495 0.664 . . . . 1.0 111.87 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.7 t -146.25 138.92 14.0 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.992 1.317 . . . . 1.0 109.445 177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.7 92.69 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.06 2.507 . . . . 1.0 112.693 -174.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.45 -33.2 73.76 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.459 1.104 . . . . 1.0 111.471 173.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 36.71 51.36 1.84 Allowed Pre-proline 0 CA--C 1.558 1.285 0 C-N-CA 126.847 2.059 . . . . 1.0 116.299 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.33 158.38 57.8 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.208 2.605 . . . . 1.0 112.731 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 N--CA 1.477 0.92 0 C-N-CA 125.726 1.61 . . . . 1.0 109.792 -179.72 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.39 0 N-CA-C 114.715 0.646 . . . . 1.0 114.715 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.1 p -55.78 -34.94 65.73 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.695 1.198 . . . . 1.0 113.859 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.65 -27.36 69.17 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -72.05 -39.5 69.03 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.319 -0.863 . . . . 1.0 111.272 172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.37 -40.22 89.58 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.738 0.815 . . . . 1.0 111.525 174.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 1.0 112.377 172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -63.14 -41.83 99.37 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.679 -0.638 . . . . 1.0 111.792 172.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -64.45 -38.28 90.49 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.544 -0.722 . . . . 1.0 112.612 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.66 92.45 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.426 0.691 . . . . 1.0 112.383 173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -65.53 -41.66 92.86 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.317 -0.865 . . . . 1.0 112.185 175.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -65.12 -35.02 79.79 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.183 -0.948 . . . . 1.0 112.573 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.8 m -66.24 -38.45 87.93 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.481 -0.762 . . . . 1.0 111.888 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 tp -69.46 -37.45 77.34 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.173 -0.955 . . . . 1.0 112.255 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.36 -36.02 72.85 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.382 -0.824 . . . . 1.0 112.046 170.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -72.22 -40.92 67.45 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.353 0.661 . . . . 1.0 112.056 176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -60.06 -39.16 85.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.835 0.854 . . . . 1.0 112.285 170.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -67.32 -42.52 83.48 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.378 0.671 . . . . 1.0 112.369 172.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.71 -26.57 68.71 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.549 1.068 . . . . 1.0 113.438 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -60.8 -30.35 70.0 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.048 -1.032 . . . . 1.0 112.799 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.5 mt -63.66 -15.09 57.4 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.706 0.802 . . . . 1.0 112.914 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -62.76 -10.76 14.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.629 1.171 . . . . 1.0 113.471 171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.87 18.16 50.67 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 1.0 113.895 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -131.32 160.16 35.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.789 1.235 . . . . 1.0 113.578 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.95 149.91 23.42 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.995 2.118 . . . . 1.0 109.399 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -142.69 -173.53 14.52 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.83 1.681 . . . . 1.0 114.803 -175.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.59 117.06 9.67 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.877 2.471 . . . . 1.0 109.551 -171.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.03 133.57 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.909 0.884 . . . . 1.0 111.511 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.29 -11.69 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.328 1.851 . . . . 1.0 113.508 -172.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 92.3 m -142.75 125.98 16.5 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 105.599 -2.0 . . . . 1.0 105.599 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.96 141.98 37.5 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.203 1.001 . . . . 1.0 113.157 -169.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.22 92.68 45.94 Favored Pre-proline 0 N--CA 1.47 0.552 0 C-N-CA 125.236 1.414 . . . . 1.0 108.062 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.85 171.31 15.92 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.337 2.025 . . . . 1.0 112.526 -175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 m -56.88 -20.21 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 115.404 1.631 . . . . 1.0 115.404 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.89 30.84 1.06 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.484 1.514 . . . . 1.0 111.332 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.25 -161.74 8.84 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.391 0.996 . . . . 1.0 114.622 -173.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -128.55 145.72 51.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.94 1.296 . . . . 1.0 112.335 -169.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -149.42 -143.96 3.86 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.53 2.014 . . . . 1.0 110.272 170.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.97 155.12 43.92 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.48 1.14 . . . . 1.0 113.019 -175.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.8 p -146.1 157.98 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.602 1.961 . . . . 1.0 111.834 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 t -128.87 145.17 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.2 1.8 . . . . 1.0 108.061 169.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.4 mm -71.83 148.39 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.542 1.065 . . . . 1.0 109.816 169.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -56.89 -15.95 5.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 116.522 2.045 . . . . 1.0 116.522 -169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.6 39.75 1.1 Allowed Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.148 1.356 . . . . 1.0 114.229 170.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.94 -26.43 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 127.505 2.322 . . . . 1.0 116.502 -169.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.18 -16.06 57.32 Favored Glycine 0 CA--C 1.542 1.755 0 C-N-CA 124.435 1.017 . . . . 1.0 115.411 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.75 -12.07 0.1 OUTLIER Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.754 1.462 . . . . 1.0 116.754 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.6 p -71.23 174.72 6.04 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 119.734 1.767 . . . . 1.0 112.795 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 86.1 mt -129.08 135.96 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.512 1.525 . . . . 1.0 109.771 -171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -66.45 149.21 50.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.681 1.192 . . . . 1.0 112.808 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -142.55 158.08 44.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.197 1.799 . . . . 1.0 110.967 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.5 m -71.42 153.36 42.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.917 0.389 . . . . 1.0 110.031 169.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.27 151.12 40.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.22 153.16 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.652 1.981 . . . . 1.0 111.461 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.1 t -86.06 104.36 15.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.792 0.837 . . . . 1.0 111.409 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -65.93 -26.58 67.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.351 1.061 . . . . 1.0 113.51 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -108.42 16.31 23.19 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.285 1.434 . . . . 1.0 112.633 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m120 49.56 47.26 22.88 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.059 1.744 . . . . 1.0 113.7 -175.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -111.17 151.05 28.63 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.251 1.42 . . . . 1.0 111.044 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -85.39 95.06 9.13 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.449 -0.574 . . . . 1.0 109.449 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.25 81.68 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.458 1.103 . . . . 1.0 108.708 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.5 m -61.15 164.18 5.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.241 1.016 . . . . 1.0 112.732 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -50.82 140.65 14.61 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.254 1.422 . . . . 1.0 113.889 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.18 41.3 39.43 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 115.942 1.137 . . . . 1.0 115.942 169.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 t -126.89 157.92 38.11 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.919 1.36 . . . . 1.0 113.061 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.8 m -90.64 126.62 36.02 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.35 1.46 . . . . 1.0 110.506 -175.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.8 145.67 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.112 1.365 . . . . 1.0 112.256 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.87 127.44 43.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 t -73.51 125.3 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.104 -1.073 . . . . 1.0 108.104 169.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.51 -20.5 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.729 1.212 . . . . 1.0 113.725 -169.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -150.47 163.09 39.28 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.63 1.572 . . . . 1.0 108.006 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.1 mt -146.68 140.09 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 120.885 -1.135 . . . . 1.0 110.994 -173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -133.98 162.32 32.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.291 2.237 . . . . 1.0 108.455 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -49.83 99.17 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.414 1.485 . . . . 1.0 114.183 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.37 10.56 57.56 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.556 1.55 . . . . 1.0 115.711 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.7 t -133.38 86.72 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 126.94 2.096 . . . . 1.0 108.517 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mp -75.11 149.58 39.04 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.794 1.238 . . . . 1.0 110.427 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m -108.66 120.01 41.22 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.234 1.014 . . . . 1.0 108.493 172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -129.71 162.14 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.449 0.7 . . . . 1.0 112.104 -169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.5 t -143.52 142.09 20.36 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.672 1.189 . . . . 1.0 110.247 176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.8 92.35 0.7 Allowed 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.069 2.512 . . . . 1.0 112.508 -177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -59.77 -37.0 77.83 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.645 1.178 . . . . 1.0 111.473 170.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 37.21 54.24 3.14 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 127.067 2.147 . . . . 1.0 115.236 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.55 157.13 63.1 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.184 2.59 . . . . 1.0 112.579 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 125.748 1.619 . . . . 1.0 109.841 -178.751 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 N-CA-C 114.747 0.659 . . . . 1.0 114.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -55.8 -29.19 59.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.327 1.451 . . . . 1.0 114.456 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -59.98 -33.24 71.69 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.691 0.797 . . . . 1.0 113.008 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -73.93 -33.35 63.9 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.545 0.738 . . . . 1.0 112.072 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.37 -41.86 75.95 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.624 0.769 . . . . 1.0 111.364 174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -63.87 -41.73 97.69 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.488 0.715 . . . . 1.0 111.992 171.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.2 m -60.8 -41.79 96.33 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.659 -0.651 . . . . 1.0 111.779 173.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.2 m -64.16 -38.7 92.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.657 0.783 . . . . 1.0 112.453 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.97 89.06 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.512 0.725 . . . . 1.0 112.497 174.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.77 -39.72 91.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.43 -0.794 . . . . 1.0 112.521 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.8 -35.24 79.61 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.235 -0.915 . . . . 1.0 112.493 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.1 m -66.02 -38.82 89.42 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.504 -0.748 . . . . 1.0 111.717 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.26 -42.55 93.15 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.421 -0.799 . . . . 1.0 110.925 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.69 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.932 0.787 . . . . 1.0 112.279 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -67.03 -40.04 87.13 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.686 0.794 . . . . 1.0 112.801 172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -65.36 -38.94 91.57 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.299 -0.876 . . . . 1.0 112.512 171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.61 -38.47 90.32 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.333 0.653 . . . . 1.0 112.031 171.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -61.92 -25.76 67.77 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 119.411 1.005 . . . . 1.0 113.273 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.18 -31.76 72.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.353 -0.842 . . . . 1.0 112.643 169.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.6 mt -72.24 -17.96 61.86 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.93 1.292 . . . . 1.0 112.518 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -66.33 -7.93 21.98 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.965 1.306 . . . . 1.0 113.256 170.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -104.12 17.68 47.6 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.487 1.518 . . . . 1.0 113.671 170.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -133.5 159.34 40.68 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.157 1.383 . . . . 1.0 113.179 -172.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.75 158.09 19.48 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.288 171.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -140.22 -173.76 13.5 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.837 2.16 . . . . 1.0 112.921 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -143.6 115.81 8.45 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 127.421 2.288 . . . . 1.0 109.552 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -73.21 132.86 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.821 0.848 . . . . 1.0 111.181 -178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -124.4 -12.88 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.988 1.715 . . . . 1.0 113.314 -173.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 84.6 m -141.58 126.98 18.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 105.938 -1.875 . . . . 1.0 105.938 169.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.15 141.03 42.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.876 0.87 . . . . 1.0 113.238 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.25 93.83 45.75 Favored Pre-proline 0 N--CA 1.468 0.471 0 C-N-CA 125.729 1.612 . . . . 1.0 107.488 -173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.39 170.21 19.82 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.158 1.906 . . . . 1.0 112.383 -176.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 m -54.45 -26.01 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 115.601 1.704 . . . . 1.0 115.601 -169.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -142.55 32.19 1.47 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.598 1.559 . . . . 1.0 111.244 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.24 -161.39 8.69 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.577 1.084 . . . . 1.0 114.356 -174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -128.77 145.74 51.1 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 1.0 112.692 -169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.6 -144.32 3.95 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.748 2.118 . . . . 1.0 110.114 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -143.41 155.49 44.41 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 118.255 1.028 . . . . 1.0 113.049 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.5 p -146.07 158.1 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 126.826 2.05 . . . . 1.0 111.303 -175.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.8 t -128.72 145.16 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.047 1.739 . . . . 1.0 108.212 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.67 148.5 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 119.897 1.226 . . . . 1.0 109.952 171.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.74 -13.76 6.85 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 116.701 2.112 . . . . 1.0 116.701 -169.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 40.78 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.317 1.436 . . . . 1.0 114.063 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 1.7 pp -47.85 -22.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 127.712 2.405 . . . . 1.0 116.947 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.9 -16.46 63.96 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.453 1.025 . . . . 1.0 115.04 170.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.3 -9.6 0.09 OUTLIER Glycine 0 CA--C 1.54 1.633 0 N-CA-C 117.064 1.586 . . . . 1.0 117.064 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.9 p -70.66 173.24 7.4 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 119.793 1.796 . . . . 1.0 113.112 173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.01 137.76 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.717 1.607 . . . . 1.0 109.779 -171.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.7 m -66.25 149.62 50.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.767 1.227 . . . . 1.0 112.962 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -142.94 159.86 41.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.217 1.807 . . . . 1.0 111.144 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 m -70.29 151.39 45.35 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.412 0.685 . . . . 1.0 110.46 169.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.79 147.96 36.36 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 113.803 1.038 . . . . 1.0 113.803 -175.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.0 m -129.13 154.66 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.967 2.107 . . . . 1.0 111.329 171.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.3 t -77.81 119.51 21.41 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.473 -0.767 . . . . 1.0 111.326 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -76.65 -15.92 59.68 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.064 0.946 . . . . 1.0 112.963 170.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -120.82 14.27 11.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.254 1.422 . . . . 1.0 112.896 -169.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.51 42.55 29.67 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.017 1.727 . . . . 1.0 113.045 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -110.17 157.3 19.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.144 1.778 . . . . 1.0 111.676 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.98 84.76 3.36 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.445 1.098 . . . . 1.0 109.406 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 mt -81.76 98.37 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.918 1.287 . . . . 1.0 109.384 -170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 t -70.68 170.16 12.9 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.826 0.822 . . . . 1.0 112.887 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -53.82 142.77 22.93 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.377 1.471 . . . . 1.0 112.802 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.82 55.68 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 116.096 1.198 . . . . 1.0 116.096 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 t -123.57 154.52 39.12 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.2 1.5 . . . . 1.0 112.42 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 42.6 m -92.67 127.29 38.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.288 1.035 . . . . 1.0 109.932 -175.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.4 m -127.92 145.15 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.492 1.517 . . . . 1.0 110.73 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.7 tp -92.71 126.95 38.03 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 169.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.68 120.34 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.97 -20.68 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.504 1.122 . . . . 1.0 113.368 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -152.12 164.73 36.68 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.322 1.449 . . . . 1.0 108.74 169.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.5 mt -147.79 138.99 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.797 -1.19 . . . . 1.0 110.588 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.85 77.57 1.79 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.106 1.762 . . . . 1.0 110.723 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 54.2 20.46 2.6 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 117.06 2.245 . . . . 1.0 117.06 169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 133.43 -17.25 4.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.009 1.29 . . . . 1.0 113.657 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.98 97.55 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.735 1.614 . . . . 1.0 107.929 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.28 147.57 36.21 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.114 0.966 . . . . 1.0 110.148 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 m -108.62 119.14 38.65 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.58 162.57 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.386 0.613 . . . . 1.0 112.353 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -143.71 140.65 17.57 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 124.694 1.198 . . . . 1.0 110.102 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.32 91.93 0.66 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.983 2.455 . . . . 1.0 112.571 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -66.5 -35.31 79.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.187 0.995 . . . . 1.0 111.245 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 39.38 53.72 4.93 Favored Pre-proline 0 CA--C 1.559 1.3 0 C-N-CA 126.703 2.001 . . . . 1.0 115.057 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.63 156.56 65.54 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.034 2.489 . . . . 1.0 112.362 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 126.048 1.739 . . . . 1.0 110.083 -176.771 . . . . . . . . 0 0 . 1 stop_ save_